ONTOLOGY REPORT - ANNOTATIONS
| Term: | regulation of primary metabolic process |
|
| Accession: | GO:0080090
|
browse the term
|
| Definition: | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways within a cell or an organism involving those compounds formed as a part of the normal anabolic and catabolic processes. These processes take place in most, if not all, cells of the organism. |
|
|
activation of adenylate cyclase activity
|
| G |
Acr |
acrosin |
|
|
ISO |
7 |
127,885,399 |
127,891,552 |
RGD:1624291 |
RGD |
| G |
Acr |
acrosin |
|
|
ISS |
7 |
127,885,399 |
127,891,552 |
RGD:1600115 |
UniProtKB |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
ISO |
18 |
58,174,958 |
58,177,000 |
RGD:1624291 |
RGD |
| G |
Adrb2 |
adrenoceptor beta 2, surface |
|
|
ISS |
18 |
58,174,958 |
58,177,000 |
RGD:1600115 |
HGNC |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
|
ISO |
16 |
69,163,620 |
69,166,384 |
RGD:1624291 |
RGD |
| G |
Adrb3 |
adrenoceptor beta 3 |
|
|
ISS |
16 |
69,163,620 |
69,166,384 |
RGD:1600115 |
HGNC |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calcr |
calcitonin receptor |
|
NOT |
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:1624291 |
RGD |
| G |
Calm1 |
calmodulin 1 |
|
|
IDA |
6 |
124,477,601 |
124,485,669 |
RGD:7241269 |
RGD |
| G |
Calm2 |
calmodulin 2 |
|
|
IDA |
6 |
64,161,641 |
64,162,751 |
RGD:7241269 |
RGD |
| G |
Calm3 |
calmodulin 3 |
|
|
IDA |
1 |
77,245,609 |
77,252,717 |
RGD:7241269 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:1624291 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:1624291 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
IEA |
17 |
16,655,926 |
16,658,161 |
RGD:1600115 |
ENSEMBL |
| G |
Drd1 |
dopamine receptor D1 |
|
|
IEA |
17 |
16,655,926 |
16,658,161 |
RGD:1600115 |
ENSEMBL |
| G |
Drd1 |
dopamine receptor D1 |
|
|
IDA |
17 |
16,655,926 |
16,658,161 |
|
BHF-UCL |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
|
IDA |
4 |
84,135,530 |
84,148,503 |
RGD:1624951 |
RGD |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
|
IDA |
4 |
84,135,530 |
84,148,503 |
RGD:1601338 |
RGD |
| G |
Gnal |
guanine nucleotide binding protein, alpha stimulating, olfactory type |
|
|
ISO |
18 |
63,595,606 |
63,735,803 |
RGD:1624291 |
RGD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
|
ISO |
6 |
12,613,622 |
12,651,587 |
RGD:1624291 |
RGD |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
|
IDA |
6 |
12,613,622 |
12,651,587 |
RGD:2292602 |
RGD |
| G |
Vipr2 |
vasoactive intestinal peptide receptor 2 |
|
|
IDA |
6 |
143,347,748 |
143,416,680 |
RGD:70054 |
RGD |
negative regulation of adenylate cyclase activity
|
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
IDA |
6 |
98,923,105 |
98,928,505 |
RGD:7242424 |
RGD |
| G |
Ccr2 |
chemokine (C-C motif) receptor 2 |
|
|
IEA |
8 |
128,892,784 |
128,893,905 |
RGD:1600115 |
InterPro |
| G |
Drd2 |
dopamine receptor D2 |
|
|
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:1624291 |
RGD |
| G |
Drd2 |
dopamine receptor D2 |
|
|
IDA |
8 |
52,641,160 |
52,707,749 |
|
BHF-UCL |
| G |
Drd3 |
dopamine receptor D3 |
|
|
ISO |
11 |
58,446,901 |
58,520,589 |
RGD:1624291 |
RGD |
| G |
Drd3 |
dopamine receptor D3 |
|
|
IDA |
11 |
58,446,901 |
58,520,589 |
|
BHF-UCL |
| G |
Drd4 |
dopamine receptor D4 |
|
|
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:1624291 |
RGD |
| G |
Drd4 |
dopamine receptor D4 |
|
|
IEA |
1 |
201,485,597 |
201,488,784 |
RGD:1600115 |
ENSEMBL |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
|
IMP |
20 |
1,553,297 |
1,582,426 |
RGD:2315493 |
RGD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
|
IDA |
20 |
1,553,297 |
1,582,426 |
RGD:632819 |
MGI |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
|
ISO |
4 |
146,952,340 |
147,270,225 |
RGD:1624291 |
RGD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
|
ISO |
4 |
146,952,340 |
147,270,225 |
RGD:1624291 |
RGD |
| G |
Hrh3 |
histamine receptor H3 |
|
|
IDA |
3 |
169,154,980 |
169,160,064 |
RGD:632981 |
RGD |
| G |
Npr3 |
natriuretic peptide receptor C/guanylate cyclase C (atrionatriuretic peptide receptor C) |
|
|
IDA |
2 |
61,278,264 |
61,341,460 |
RGD:1601497 |
RGD |
| G |
Palm |
paralemmin |
|
|
ISO |
7 |
11,399,529 |
11,425,964 |
RGD:1624291 |
RGD |
| G |
Palm |
paralemmin |
|
|
ISO |
7 |
11,399,529 |
11,425,964 |
RGD:1624291 |
RGD |
| G |
Palm |
paralemmin |
|
|
IEA |
7 |
11,399,529 |
11,425,964 |
RGD:1600115 |
ENSEMBL |
| G |
Palm |
paralemmin |
|
|
IEA |
7 |
11,399,529 |
11,425,964 |
RGD:1600115 |
ENSEMBL |
negative regulation of aldosterone biosynthetic process
|
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:1624291 |
RGD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
IEA |
3 |
121,372,692 |
121,381,236 |
RGD:1600115 |
ENSEMBL |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
|
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:1624291 |
RGD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
|
IEA |
8 |
80,593,053 |
80,717,015 |
RGD:1600115 |
ENSEMBL |
| G |
Dkk3 |
dickkopf 3 homolog (Xenopus laevis) |
|
|
ISO |
1 |
169,924,617 |
169,964,692 |
RGD:1624291 |
RGD |
| G |
Dkk3 |
dickkopf 3 homolog (Xenopus laevis) |
|
|
IEA |
1 |
169,924,617 |
169,964,692 |
RGD:1600115 |
ENSEMBL |
| G |
Rest |
RE1-silencing transcription factor |
|
|
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:1624291 |
RGD |
| G |
Rest |
RE1-silencing transcription factor |
|
|
IMP |
14 |
33,136,046 |
33,151,142 |
RGD:4891166 |
UniProtKB |
negative regulation of bile acid biosynthetic process
|
| G |
Fgf19 |
fibroblast growth factor 19 |
|
|
ISO |
1 |
205,324,890 |
205,328,178 |
RGD:1624291 |
RGD |
| G |
Fgf19 |
fibroblast growth factor 19 |
|
|
IEA |
1 |
205,324,890 |
205,328,178 |
RGD:1600115 |
ENSEMBL |
| G |
Prox1 |
prospero homeobox 1 |
|
|
IEA |
13 |
106,421,541 |
106,471,350 |
RGD:1600115 |
ENSEMBL |
| G |
Prox1 |
prospero homeobox 1 |
|
|
ISO |
13 |
106,421,541 |
106,471,350 |
RGD:1624291 |
RGD |
negative regulation of cAMP biosynthetic process
|
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
|
IMP |
7 |
101,957,807 |
102,210,346 |
RGD:7241269 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Akap6 |
A kinase (PRKA) anchor protein 6 |
|
|
IMP |
6 |
73,010,779 |
73,354,520 |
RGD:6902943 |
RGD |
| G |
Aplp1 |
amyloid beta (A4) precursor-like protein 1 |
|
|
ISO |
1 |
85,390,217 |
85,401,952 |
RGD:1624291 |
RGD |
| G |
Ccr5 |
chemokine (C-C motif) receptor 5 |
|
|
IEA |
8 |
128,907,157 |
128,912,272 |
RGD:1600115 |
InterPro |
| G |
Ccr6 |
chemokine (C-C motif) receptor 6 |
|
|
IEA |
1 |
47,115,472 |
47,139,825 |
RGD:1600115 |
InterPro |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
|
IDA |
4 |
83,839,822 |
83,867,017 |
RGD:5491003 |
RGD |
| G |
Cxcr1 |
chemokine (C-X-C motif) receptor 1 |
|
|
IEA |
9 |
73,510,488 |
73,511,537 |
RGD:1600115 |
InterPro |
| G |
Cxcr2 |
chemokine (C-X-C motif) receptor 2 |
|
|
IEA |
9 |
73,470,943 |
73,477,315 |
RGD:1600115 |
InterPro |
| G |
Drd4 |
dopamine receptor D4 |
|
|
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:1624291 |
RGD |
| G |
Drd4 |
dopamine receptor D4 |
|
|
ISO |
1 |
201,485,597 |
201,488,784 |
RGD:1624291 |
RGD |
| G |
Edn1 |
endothelin 1 |
|
|
IEA |
17 |
28,303,886 |
28,309,775 |
RGD:1600115 |
ENSEMBL |
| G |
Ednra |
endothelin receptor type A |
|
|
ISO |
19 |
32,042,366 |
32,108,153 |
RGD:1624291 |
RGD |
| G |
Ednra |
endothelin receptor type A |
|
|
IEA |
19 |
32,042,366 |
32,108,153 |
RGD:1600115 |
ENSEMBL |
| G |
Galr3 |
galanin receptor 3 |
|
|
IMP |
7 |
117,014,148 |
117,017,058 |
RGD:2325185 |
RGD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
|
ISO |
4 |
146,952,340 |
147,270,225 |
RGD:1624291 |
RGD |
| G |
Grm7 |
glutamate receptor, metabotropic 7 |
|
|
ISO |
4 |
146,952,340 |
147,270,225 |
RGD:1624291 |
RGD |
| G |
Grm8 |
glutamate receptor, metabotropic 8 |
|
|
ISO |
4 |
53,976,781 |
54,902,331 |
RGD:1624291 |
RGD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
|
ISO |
8 |
86,700,088 |
86,701,248 |
RGD:1624291 |
RGD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
|
ISO |
8 |
86,700,088 |
86,701,248 |
RGD:1624291 |
RGD |
| G |
Htr1b |
5-hydroxytryptamine (serotonin) receptor 1B, G protein-coupled |
|
|
IEA |
8 |
86,700,088 |
86,701,248 |
RGD:1600115 |
ENSEMBL |
| G |
Npy2r |
neuropeptide Y receptor Y2 |
|
|
IMP |
2 |
150,554,962 |
150,556,108 |
RGD:633494 |
RGD |
| G |
Palm |
paralemmin |
|
|
ISO |
7 |
11,399,529 |
11,425,964 |
RGD:1624291 |
RGD |
| G |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
|
|
IMP |
1 |
158,921,607 |
159,013,829 |
|
UniProtKB |
| G |
Pde2a |
phosphodiesterase 2A, cGMP-stimulated |
|
|
ISO |
1 |
158,921,607 |
159,013,829 |
RGD:1624291 |
RGD |
negative regulation of cAMP metabolic process
|
| G |
Chrm2 |
cholinergic receptor, muscarinic 2 |
|
|
IEA |
4 |
63,911,292 |
63,913,354 |
RGD:1600115 |
InterPro |
| G |
Chrm5 |
cholinergic receptor, muscarinic 5 |
|
|
IEA |
3 |
98,326,809 |
98,378,531 |
RGD:1600115 |
InterPro |
| G |
Htr1a |
5-hydroxytryptamine (serotonin) receptor 1A, G protein-coupled |
|
|
IEA |
2 |
36,434,518 |
36,435,786 |
RGD:1600115 |
InterPro |
| G |
Htr1d |
5-hydroxytryptamine (serotonin) receptor 1D, G protein-coupled |
|
|
IEA |
5 |
155,188,669 |
155,189,793 |
RGD:1600115 |
InterPro |
| G |
Htr1f |
5-hydroxytryptamine (serotonin) receptor 1F, G protein-coupled |
|
|
IEA |
11 |
2,260,587 |
2,261,687 |
RGD:1600115 |
InterPro |
| G |
Htr5a |
5-hydroxytryptamine (serotonin) receptor 5A, G protein-coupled |
|
|
IEA |
4 |
2,707,261 |
2,716,944 |
RGD:1600115 |
InterPro |
| G |
Sstr4 |
somatostatin receptor 4 |
|
|
IDA |
3 |
137,150,419 |
137,152,284 |
RGD:2325010 |
RGD |
negative regulation of cholesterol biosynthetic process
|
| G |
Apoe |
apolipoprotein E |
|
|
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:1624291 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
IEA |
1 |
79,003,634 |
79,006,387 |
RGD:1600115 |
ENSEMBL |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISO |
11 |
29,810,766 |
29,816,342 |
RGD:1624291 |
RGD |
| G |
Sod1 |
superoxide dismutase 1, soluble |
|
|
ISS |
11 |
29,810,766 |
29,816,342 |
RGD:1600115 |
UniProtKB |
negative regulation of cortisol biosynthetic process
|
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:1624291 |
RGD |
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
IEA |
3 |
121,372,692 |
121,381,236 |
RGD:1600115 |
ENSEMBL |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
|
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:1624291 |
RGD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
|
IEA |
8 |
80,593,053 |
80,717,015 |
RGD:1600115 |
ENSEMBL |
| G |
Dkk3 |
dickkopf 3 homolog (Xenopus laevis) |
|
|
ISO |
1 |
169,924,617 |
169,964,692 |
RGD:1624291 |
RGD |
| G |
Dkk3 |
dickkopf 3 homolog (Xenopus laevis) |
|
|
IEA |
1 |
169,924,617 |
169,964,692 |
RGD:1600115 |
ENSEMBL |
| G |
Rest |
RE1-silencing transcription factor |
|
|
ISO |
14 |
33,136,046 |
33,151,142 |
RGD:1624291 |
RGD |
| G |
Rest |
RE1-silencing transcription factor |
|
|
IMP |
14 |
33,136,046 |
33,151,142 |
RGD:4891166 |
UniProtKB |
negative regulation of fatty acid beta-oxidation
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IEA |
6 |
137,640,482 |
137,657,552 |
RGD:1600115 |
ENSEMBL |
| G |
Cnr1 |
cannabinoid receptor 1 (brain) |
|
|
IMP |
5 |
50,427,173 |
50,445,471 |
RGD:2314644 |
RGD |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
|
IDA |
|
|
|
RGD:2316274 |
RGD |
negative regulation of fatty acid biosynthetic process
|
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:1624291 |
RGD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
IEA |
9 |
65,613,130 |
65,651,775 |
RGD:1600115 |
ENSEMBL |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:1624291 |
RGD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
IEA |
10 |
56,856,233 |
56,861,380 |
RGD:1600115 |
ENSEMBL |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISO |
1 |
78,996,677 |
78,999,960 |
RGD:1624291 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Brca1 |
breast cancer 1, early onset |
|
|
ISO |
10 |
90,513,630 |
90,572,676 |
RGD:1624291 |
RGD |
| G |
Brca1 |
breast cancer 1, early onset |
|
|
ISS |
10 |
90,513,630 |
90,572,676 |
RGD:1600115 |
UniProtKB |
| G |
Insig1 |
insulin induced gene 1 |
|
|
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:1624291 |
RGD |
| G |
Insig2 |
insulin induced gene 2 |
|
|
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:1624291 |
RGD |
| G |
Insig2 |
insulin induced gene 2 |
|
|
IEA |
13 |
33,331,951 |
33,345,132 |
RGD:1600115 |
ENSEMBL |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
|
ISO |
3 |
142,664,641 |
142,670,135 |
RGD:1624291 |
RGD |
| G |
Trib3 |
tribbles homolog 3 (Drosophila) |
|
|
IEA |
3 |
142,664,641 |
142,670,135 |
RGD:1600115 |
ENSEMBL |
| G |
Wdtc1 |
WD and tetratricopeptide repeats 1 |
|
|
ISO |
5 |
151,784,746 |
151,834,368 |
RGD:1624291 |
RGD |
| G |
Wdtc1 |
WD and tetratricopeptide repeats 1 |
|
|
IEA |
5 |
151,784,746 |
151,834,368 |
RGD:1600115 |
ENSEMBL |
negative regulation of fatty acid metabolic process
|
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Ugt1a9 |
UDP glucuronosyltransferase 1 family, polypeptide A9 |
|
|
ISO |
9 |
86,986,915 |
87,098,362 |
RGD:1624291 |
RGD |
negative regulation of fatty acid oxidation
|
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:1624291 |
RGD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
IEA |
9 |
65,613,130 |
65,651,775 |
RGD:1600115 |
ENSEMBL |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:1624291 |
RGD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
IEA |
10 |
56,856,233 |
56,861,380 |
RGD:1600115 |
ENSEMBL |
negative regulation of glucocorticoid biosynthetic process
|
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
|
ISO |
2 |
196,657,749 |
196,687,242 |
RGD:1624291 |
RGD |
| G |
Atp1a1 |
ATPase, Na+/K+ transporting, alpha 1 polypeptide |
|
|
IEA |
2 |
196,657,749 |
196,687,242 |
RGD:1600115 |
ENSEMBL |
negative regulation of glucokinase activity
|
| G |
Foxa2 |
forkhead box A2 |
|
|
ISO |
3 |
136,739,009 |
136,743,204 |
RGD:1624291 |
RGD |
| G |
Foxa2 |
forkhead box A2 |
|
|
IEA |
3 |
136,739,009 |
136,743,204 |
RGD:1600115 |
ENSEMBL |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
IDA |
|
|
|
RGD:1598592 |
BHF-UCL |
negative regulation of gluconeogenesis
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:1624291 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:1600115 |
UniProtKB |
| G |
C1qtnf3 |
C1q and tumor necrosis factor related protein 3 |
|
|
IEA |
2 |
60,303,261 |
60,325,510 |
RGD:1600115 |
ENSEMBL |
| G |
C1qtnf3 |
C1q and tumor necrosis factor related protein 3 |
|
|
IEA |
2 |
60,303,261 |
60,325,510 |
RGD:1600115 |
ENSEMBL |
| G |
C1qtnf3 |
C1q and tumor necrosis factor related protein 3 |
|
|
ISO |
2 |
60,303,261 |
60,325,510 |
RGD:1624291 |
RGD |
| G |
C1qtnf3 |
C1q and tumor necrosis factor related protein 3 |
|
|
ISO |
2 |
60,303,261 |
60,325,510 |
RGD:1624291 |
RGD |
| G |
Clk2 |
CDC-like kinase 2 |
|
|
ISO |
2 |
181,244,665 |
181,257,364 |
RGD:1624291 |
RGD |
| G |
Clk2 |
CDC-like kinase 2 |
|
|
IEA |
2 |
181,244,665 |
181,257,364 |
RGD:1600115 |
ENSEMBL |
| G |
Fam132a |
family with sequence similarity 132, member A |
|
|
ISO |
5 |
172,801,076 |
172,805,451 |
RGD:1624291 |
RGD |
| G |
Fam132a |
family with sequence similarity 132, member A |
|
|
IEA |
5 |
172,801,076 |
172,805,451 |
RGD:1600115 |
ENSEMBL |
| G |
Gck |
glucokinase |
|
|
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:1624291 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:1600115 |
UniProtKB |
| G |
Il6 |
interleukin 6 |
|
|
IDA |
4 |
456,799 |
461,376 |
RGD:2306940 |
RGD |
| G |
LOC259246 |
alpha-2u globulin PGCL1 |
|
|
ISS |
5 |
78,707,324 |
78,710,745 |
RGD:1600115 |
UniProtKB |
| G |
Sik1 |
salt-inducible kinase 1 |
|
|
ISO |
20 |
10,282,203 |
10,291,735 |
RGD:1624291 |
RGD |
| G |
Sik1 |
salt-inducible kinase 1 |
|
|
ISS |
20 |
10,282,203 |
10,291,735 |
RGD:1600115 |
UniProtKB |
negative regulation of glutamate metabolic process
|
| G |
Atcay |
ataxia, cerebellar, Cayman type |
|
|
ISO |
7 |
9,971,563 |
9,995,528 |
RGD:1624291 |
RGD |
| G |
Atcay |
ataxia, cerebellar, Cayman type |
|
|
ISS |
7 |
9,971,563 |
9,995,528 |
RGD:1600115 |
UniProtKB |
negative regulation of glycogen biosynthetic process
|
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
ISO |
1 |
21,223,678 |
21,287,411 |
RGD:1624291 |
RGD |
| G |
Enpp1 |
ectonucleotide pyrophosphatase/phosphodiesterase 1 |
|
|
IEA |
1 |
21,223,678 |
21,287,411 |
RGD:1600115 |
ENSEMBL |
| G |
Gfpt1 |
glutamine fructose-6-phosphate transaminase 1 |
|
|
IMP |
4 |
121,204,274 |
121,250,160 |
RGD:1625425 |
RGD |
| G |
Grb10 |
growth factor receptor bound protein 10 |
|
|
IDA |
14 |
92,814,797 |
92,911,442 |
|
BHF-UCL |
| G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
|
|
ISO |
10 |
62,953,425 |
62,971,016 |
RGD:1624291 |
RGD |
| G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
|
|
ISO |
10 |
62,953,425 |
62,971,016 |
RGD:1624291 |
RGD |
| G |
Pask |
PAS domain containing serine/threonine kinase |
|
|
ISO |
9 |
92,582,177 |
92,623,004 |
RGD:1624291 |
RGD |
| G |
Pask |
PAS domain containing serine/threonine kinase |
|
|
IEA |
9 |
92,582,177 |
92,623,004 |
RGD:1600115 |
ENSEMBL |
negative regulation of glycogen catabolic process
|
| G |
Adra1b |
adrenoceptor alpha 1B |
|
|
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:1624291 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
negative regulation of glycolysis
|
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
|
ISO |
20 |
27,252,273 |
27,254,371 |
RGD:1624291 |
RGD |
| G |
Ddit4 |
DNA-damage-inducible transcript 4 |
|
|
IEA |
20 |
27,252,273 |
27,254,371 |
RGD:1600115 |
ENSEMBL |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
|
ISO |
17 |
7,795,717 |
7,818,041 |
RGD:1624291 |
RGD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
|
ISS |
17 |
7,795,717 |
7,818,041 |
RGD:1600115 |
UniProtKB |
| G |
Hdac4 |
histone deacetylase 4 |
|
|
ISO |
9 |
91,147,435 |
91,389,810 |
RGD:1624291 |
RGD |
| G |
Hdac4 |
histone deacetylase 4 |
|
|
IEA |
9 |
91,147,435 |
91,389,810 |
RGD:1600115 |
ENSEMBL |
| G |
Ier3 |
immediate early response 3 |
|
|
ISO |
20 |
3,076,568 |
3,077,772 |
RGD:1624291 |
RGD |
| G |
Ier3 |
immediate early response 3 |
|
|
IEA |
20 |
3,076,568 |
3,077,772 |
RGD:1600115 |
ENSEMBL |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IMP |
14 |
64,278,115 |
64,370,912 |
RGD:7242186 |
RGD |
negative regulation of guanylate cyclase activity
|
| G |
Pdzd3 |
PDZ domain containing 3 |
|
|
ISO |
8 |
47,225,222 |
47,229,670 |
RGD:1624291 |
RGD |
negative regulation of hyaluronan biosynthetic process
|
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
UniProtKB |
negative regulation of inositol phosphate biosynthetic process
|
| G |
Plek |
pleckstrin |
|
|
ISO |
14 |
97,841,595 |
97,875,052 |
RGD:1624291 |
RGD |
| G |
Plek |
pleckstrin |
|
|
ISO |
14 |
97,841,595 |
97,875,052 |
RGD:1624291 |
RGD |
| G |
Plek |
pleckstrin |
|
|
IEA |
14 |
97,841,595 |
97,875,052 |
RGD:1600115 |
ENSEMBL |
negative regulation of lipid biosynthetic process
|
| G |
LOC259246 |
alpha-2u globulin PGCL1 |
|
|
ISS |
5 |
78,707,324 |
78,710,745 |
RGD:1600115 |
UniProtKB |
negative regulation of lipid catabolic process
|
| G |
Adora1 |
adenosine A1 receptor |
|
|
IDA |
13 |
47,160,292 |
47,192,804 |
RGD:1625243 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Adra2a |
adrenoceptor alpha 2A |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:1624291 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
IEA |
13 |
87,114,734 |
87,116,372 |
RGD:1600115 |
ENSEMBL |
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISO |
1 |
78,996,677 |
78,999,960 |
RGD:1624291 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
|
ISO |
1 |
211,509,675 |
211,518,963 |
RGD:1624291 |
RGD |
| G |
Bscl2 |
Berardinelli-Seip congenital lipodystrophy 2 (seipin) |
|
|
ISS |
1 |
211,509,675 |
211,518,963 |
RGD:1600115 |
UniProtKB |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
|
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:1624291 |
RGD |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
|
IEA |
18 |
63,871,538 |
63,896,975 |
RGD:1600115 |
ENSEMBL |
| G |
Cidea |
cell death-inducing DFFA-like effector a |
|
|
ISO |
18 |
63,871,538 |
63,896,975 |
RGD:1624291 |
RGD |
| G |
Gimap5 |
GTPase, IMAP family member 5 |
|
|
IMP |
4 |
76,836,521 |
76,843,214 |
RGD:2293508 |
RGD |
| G |
Hcar2 |
hydroxycarboxylic acid receptor 2 |
|
|
IDA |
12 |
33,863,876 |
33,864,958 |
|
UniProtKB |
| G |
Il1b |
interleukin 1 beta |
|
|
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEA |
3 |
116,964,422 |
116,970,867 |
RGD:1600115 |
ENSEMBL |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
|
ISO |
1 |
172,409,282 |
172,577,108 |
RGD:1624291 |
RGD |
| G |
Pde3b |
phosphodiesterase 3B, cGMP-inhibited |
|
|
IEA |
1 |
172,409,282 |
172,577,108 |
RGD:1600115 |
ENSEMBL |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
ISO |
2 |
54,327,821 |
54,360,462 |
RGD:1624291 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
ISS |
2 |
54,327,821 |
54,360,462 |
RGD:1600115 |
UniProtKB |
| G |
Tnf |
tumor necrosis factor |
|
|
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:1624291 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEA |
20 |
3,661,000 |
3,663,618 |
RGD:1600115 |
ENSEMBL |
negative regulation of lipid kinase activity
|
| G |
Ppp2r5a |
protein phosphatase 2, regulatory subunit B', alpha |
|
|
ISO |
13 |
107,413,761 |
107,458,156 |
RGD:1624291 |
RGD |
negative regulation of lipid metabolic process
|
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISO |
1 |
78,996,677 |
78,999,960 |
RGD:1624291 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:1624291 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
IEA |
1 |
78,979,034 |
78,984,002 |
RGD:1600115 |
ENSEMBL |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:1624291 |
RGD |
negative regulation of lipoprotein lipid oxidation
|
| G |
Apod |
apolipoprotein D |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apod |
apolipoprotein D |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apod |
apolipoprotein D |
|
|
ISS |
|
|
|
RGD:1600115 |
UniProtKB |
negative regulation of phosphatidylcholine biosynthetic process
|
| G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
|
|
ISO |
1 |
30,573,254 |
30,624,147 |
RGD:1624291 |
RGD |
| G |
Lpcat1 |
lysophosphatidylcholine acyltransferase 1 |
|
|
IEA |
1 |
30,573,254 |
30,624,147 |
RGD:1600115 |
ENSEMBL |
negative regulation of phosphatidylcholine catabolic process
|
| G |
Apoc1 |
apolipoprotein C-I |
|
|
ISO |
1 |
78,996,677 |
78,999,960 |
RGD:1624291 |
RGD |
negative regulation of phosphatidylinositol 3-kinase activity
|
| G |
Dab2ip |
DAB2 interacting protein |
|
|
ISO |
3 |
14,667,700 |
14,840,625 |
RGD:1624291 |
RGD |
| G |
Dab2ip |
DAB2 interacting protein |
|
|
ISS |
3 |
14,667,700 |
14,840,625 |
RGD:1600115 |
UniProtKB |
| G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
|
|
ISO |
14 |
83,955,895 |
83,967,828 |
RGD:1624291 |
RGD |
| G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
|
|
ISO |
14 |
83,955,895 |
83,967,828 |
RGD:1624291 |
RGD |
| G |
Pik3ip1 |
phosphoinositide-3-kinase interacting protein 1 |
|
|
ISS |
14 |
83,955,895 |
83,967,828 |
RGD:1600115 |
UniProtKB |
negative regulation of phosphatidylinositol biosynthetic process
|
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISO |
12 |
16,151,045 |
16,172,412 |
RGD:1624291 |
RGD |
| G |
Pdgfa |
platelet-derived growth factor alpha polypeptide |
|
|
ISS |
12 |
16,151,045 |
16,172,412 |
RGD:1600115 |
UniProtKB |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IEA |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISS |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
UniProtKB |
negative regulation of phospholipid biosynthetic process
|
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
|
ISO |
16 |
18,769,909 |
18,786,988 |
RGD:1624291 |
RGD |
| G |
Slc27a1 |
solute carrier family 27 (fatty acid transporter), member 1 |
|
|
IEA |
16 |
18,769,909 |
18,786,988 |
RGD:1600115 |
ENSEMBL |
negative regulation of prostaglandin biosynthetic process
|
| G |
Sirt1 |
sirtuin 1 |
|
|
IEA |
20 |
25,675,302 |
25,686,494 |
RGD:1600115 |
ENSEMBL |
| G |
Sirt1 |
sirtuin 1 |
|
|
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:1624291 |
RGD |
negative regulation of protein ADP-ribosylation
|
| G |
Tinf2 |
TERF1 (TRF1)-interacting nuclear factor 2 |
|
|
ISO |
15 |
33,828,924 |
33,832,032 |
RGD:1624291 |
RGD |
| G |
Tinf2 |
TERF1 (TRF1)-interacting nuclear factor 2 |
|
|
IEA |
15 |
33,828,924 |
33,832,032 |
RGD:1600115 |
ENSEMBL |
negative regulation of protein glycosylation
|
| G |
Mgea5 |
meningioma expressed antigen 5 (hyaluronidase) |
|
|
IMP |
1 |
250,966,386 |
251,000,363 |
RGD:2305959 |
RGD |
negative regulation of protein glycosylation in Golgi
|
| G |
Acer2 |
alkaline ceramidase 2 |
|
|
IEA |
5 |
106,185,779 |
106,237,588 |
RGD:1600115 |
ENSEMBL |
| G |
Acer2 |
alkaline ceramidase 2 |
|
|
ISO |
5 |
106,185,779 |
106,237,588 |
RGD:1624291 |
RGD |
negative regulation of retinoic acid biosynthetic process
|
| G |
Akr1c3 |
aldo-keto reductase family 1, member C3 |
|
|
ISO |
17 |
77,269,626 |
77,286,521 |
RGD:1624291 |
RGD |
negative regulation of steroid biosynthetic process
|
| G |
Bmp2 |
bone morphogenetic protein 2 |
|
|
ISO |
3 |
121,372,692 |
121,381,236 |
RGD:1624291 |
RGD |
| G |
Bmp5 |
bone morphogenetic protein 5 |
|
|
ISO |
8 |
80,593,053 |
80,717,015 |
RGD:1624291 |
RGD |
| G |
Hrh1 |
histamine receptor H 1 |
|
|
IMP |
4 |
150,431,239 |
150,432,699 |
RGD:2316921 |
RGD |
| G |
Insig1 |
insulin induced gene 1 |
|
|
ISO |
4 |
2,577,468 |
2,585,682 |
RGD:1624291 |
RGD |
| G |
Insig2 |
insulin induced gene 2 |
|
|
ISO |
13 |
33,331,951 |
33,345,132 |
RGD:1624291 |
RGD |
| G |
Insig2 |
insulin induced gene 2 |
|
|
IEA |
13 |
33,331,951 |
33,345,132 |
RGD:1600115 |
ENSEMBL |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
negative regulation of steroid metabolic process
|
| G |
Yy1 |
YY1 transcription factor |
|
|
NAS |
6 |
133,132,419 |
133,156,686 |
RGD:634518 |
RGD |
negative regulation of testosterone biosynthetic process
|
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
IEA |
5 |
156,064,371 |
156,083,198 |
RGD:1600115 |
ENSEMBL |
negative regulation of triglyceride biosynthetic process
|
| G |
Sik1 |
salt-inducible kinase 1 |
|
|
ISO |
20 |
10,282,203 |
10,291,735 |
RGD:1624291 |
RGD |
| G |
Sik1 |
salt-inducible kinase 1 |
|
|
ISS |
20 |
10,282,203 |
10,291,735 |
RGD:1600115 |
UniProtKB |
negative regulation of triglyceride catabolic process
|
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apoc3 |
apolipoprotein C-III |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISS |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
UniProtKB |
| G |
Pik3cg |
phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma |
|
|
IMP |
6 |
50,441,892 |
50,476,931 |
RGD:6482711 |
RGD |
negative regulation of vitamin D biosynthetic process
|
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
|
ISO |
3 |
158,676,980 |
158,681,471 |
RGD:1624291 |
RGD |
| G |
Snai1 |
snail homolog 1 (Drosophila) |
|
|
IEA |
3 |
158,676,980 |
158,681,471 |
RGD:1600115 |
ENSEMBL |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Snai2 |
snail homolog 2 (Drosophila) |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
positive regulation of 1-phosphatidylinositol 4-kinase activity
|
| G |
Cd81 |
Cd81 molecule |
|
|
ISO |
1 |
203,327,287 |
203,342,901 |
RGD:1624291 |
RGD |
| G |
Cd81 |
Cd81 molecule |
|
|
ISS |
1 |
203,327,287 |
203,342,901 |
RGD:1600115 |
UniProtKB |
| G |
Cd81 |
Cd81 molecule |
|
|
IEA |
1 |
203,327,287 |
203,342,901 |
RGD:1600115 |
ENSEMBL |
positive regulation of adenylate cyclase activity
|
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
IMP |
1 |
263,025,655 |
263,027,055 |
RGD:6893643 |
RGD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
IDA |
6 |
98,923,105 |
98,928,505 |
RGD:7242424 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
IEA |
1 |
172,686,168 |
172,691,061 |
RGD:1600115 |
ENSEMBL |
| G |
Calcr |
calcitonin receptor |
|
|
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:1624291 |
RGD |
| G |
Calcr |
calcitonin receptor |
|
|
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:1624291 |
RGD |
| G |
Calcr |
calcitonin receptor |
|
|
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:1624291 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
IDA |
17 |
16,655,926 |
16,658,161 |
|
BHF-UCL |
| G |
Drd5 |
dopamine receptor D5 |
|
|
ISO |
14 |
77,768,060 |
77,769,487 |
RGD:1624291 |
RGD |
| G |
Nf1 |
neurofibromin 1 |
|
|
ISO |
10 |
65,574,833 |
65,766,305 |
RGD:1624291 |
RGD |
| G |
Nf1 |
neurofibromin 1 |
|
|
ISS |
10 |
65,574,833 |
65,766,305 |
RGD:1600115 |
HGNC |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
|
IMP |
10 |
108,310,473 |
108,358,821 |
RGD:1598578 |
RGD |
positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway
|
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
IDA |
|
|
|
|
BHF-UCL |
| G |
Drd1 |
dopamine receptor D1 |
|
|
IEA |
17 |
16,655,926 |
16,658,161 |
RGD:1600115 |
InterPro |
| G |
Drd5 |
dopamine receptor D5 |
|
|
IEA |
14 |
77,768,060 |
77,769,487 |
RGD:1600115 |
InterPro |
| G |
Vip |
vasoactive intestinal peptide |
|
|
ISO |
1 |
36,361,513 |
36,369,594 |
RGD:1624291 |
RGD |
| G |
Vip |
vasoactive intestinal peptide |
|
|
ISO |
1 |
36,361,513 |
36,369,594 |
RGD:1624291 |
RGD |
| G |
Vip |
vasoactive intestinal peptide |
|
|
IDA |
1 |
36,361,513 |
36,369,594 |
|
BHF-UCL |
positive regulation of aldosterone biosynthetic process
|
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
|
ISO |
17 |
32,380,199 |
32,689,295 |
RGD:1624291 |
RGD |
| G |
Bmp6 |
bone morphogenetic protein 6 |
|
|
IEA |
17 |
32,380,199 |
32,689,295 |
RGD:1600115 |
ENSEMBL |
| G |
Dab2 |
disabled 2, mitogen-responsive phosphoprotein |
|
|
IDA |
2 |
55,714,874 |
55,736,370 |
RGD:7243836 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
IEA |
5 |
156,064,371 |
156,083,198 |
RGD:1600115 |
ENSEMBL |
positive regulation of ammonia assimilation cycle
|
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
|
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:1624291 |
RGD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
|
IEA |
7 |
26,189,759 |
26,307,061 |
RGD:1600115 |
ENSEMBL |
positive regulation of cAMP biosynthetic process
|
| G |
Abca1 |
ATP-binding cassette, subfamily A (ABC1), member 1 |
|
|
ISO |
5 |
70,493,357 |
70,583,729 |
RGD:1624291 |
RGD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
|
IMP |
19 |
20,051,639 |
20,073,861 |
RGD:2316039 |
RGD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
|
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:1624291 |
RGD |
| G |
Adcy7 |
adenylate cyclase 7 |
|
|
ISO |
19 |
20,051,639 |
20,073,861 |
RGD:1624291 |
RGD |
| G |
Adcy8 |
adenylate cyclase 8 (brain) |
|
|
IMP |
7 |
101,957,807 |
102,210,346 |
RGD:7241269 |
RGD |
| G |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
|
|
IDA |
|
|
|
RGD:2325275 |
RGD |
| G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
|
|
IDA |
4 |
84,209,729 |
84,254,982 |
RGD:2315974 |
RGD |
| G |
Adm |
adrenomedullin |
|
|
ISO |
1 |
168,380,255 |
168,382,426 |
RGD:1624291 |
RGD |
| G |
Adm |
adrenomedullin |
|
|
IEA |
1 |
168,380,255 |
168,382,426 |
RGD:1600115 |
ENSEMBL |
| G |
Adora2a |
adenosine A2a receptor |
|
|
ISO |
20 |
13,815,719 |
13,834,131 |
RGD:1624291 |
RGD |
| G |
Adora2a |
adenosine A2a receptor |
|
|
IEA |
20 |
13,815,719 |
13,834,131 |
RGD:1600115 |
ENSEMBL |
| G |
Adora2b |
adenosine A2B receptor |
|
|
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:1624291 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:1624291 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
IMP |
10 |
48,421,592 |
48,437,967 |
RGD:2316150 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
IEA |
10 |
48,421,592 |
48,437,967 |
RGD:1600115 |
ENSEMBL |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
ISO |
1 |
263,025,655 |
263,027,055 |
RGD:1624291 |
RGD |
| G |
Adrb1 |
adrenoceptor beta 1 |
|
|
IMP |
1 |
263,025,655 |
263,027,055 |
RGD:5129138 |
RGD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
|
ISO |
1 |
34,979,039 |
35,068,763 |
RGD:1624291 |
RGD |
| G |
Akap12 |
A kinase (PRKA) anchor protein 12 |
|
|
IEA |
1 |
34,979,039 |
35,068,763 |
RGD:1600115 |
ENSEMBL |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
ISO |
6 |
98,923,105 |
98,928,505 |
RGD:1624291 |
RGD |
| G |
Akap5 |
A kinase (PRKA) anchor protein 5 |
|
|
IEA |
6 |
98,923,105 |
98,928,505 |
RGD:1600115 |
ENSEMBL |
| G |
Avp |
arginine vasopressin |
|
|
ISO |
3 |
118,205,007 |
118,206,985 |
RGD:1624291 |
RGD |
| G |
Avp |
arginine vasopressin |
|
|
IEA |
3 |
118,205,007 |
118,206,985 |
RGD:1600115 |
ENSEMBL |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calca |
calcitonin-related polypeptide alpha |
|
|
ISO |
1 |
172,686,168 |
172,691,061 |
RGD:1624291 |
RGD |
| G |
Calcr |
calcitonin receptor |
|
|
ISO |
4 |
28,486,176 |
28,561,296 |
RGD:1624291 |
RGD |
| G |
Calcrl |
calcitonin receptor-like |
|
|
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:1624291 |
RGD |
| G |
Calcrl |
calcitonin receptor-like |
|
|
ISO |
3 |
67,553,022 |
67,646,877 |
RGD:1624291 |
RGD |
| G |
Calcrl |
calcitonin receptor-like |
|
|
IEA |
3 |
67,553,022 |
67,646,877 |
RGD:1600115 |
ENSEMBL |
| G |
Crh |
corticotropin releasing hormone |
|
|
IDA |
2 |
104,764,023 |
104,765,887 |
RGD:70047 |
RGD |
| G |
Crhr1 |
corticotropin releasing hormone receptor 1 |
|
|
IMP |
10 |
93,312,405 |
93,354,229 |
RGD:5491010 |
RGD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
|
IDA |
4 |
83,839,822 |
83,867,017 |
RGD:5491010 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
IMP |
17 |
16,655,926 |
16,658,161 |
RGD:1581394 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:1624291 |
RGD |
| G |
Drd1 |
dopamine receptor D1 |
|
|
ISO |
17 |
16,655,926 |
16,658,161 |
RGD:1624291 |
RGD |
| G |
Drd5 |
dopamine receptor D5 |
|
|
IMP |
14 |
77,768,060 |
77,769,487 |
RGD:1581394 |
RGD |
| G |
Ece1 |
endothelin converting enzyme 1 |
|
|
IMP |
5 |
156,635,656 |
156,735,783 |
RGD:7243859 |
RGD |
| G |
Gcg |
glucagon |
|
|
ISO |
3 |
44,433,180 |
44,438,004 |
RGD:1624291 |
RGD |
| G |
Gcg |
glucagon |
|
|
IEA |
3 |
44,433,180 |
44,438,004 |
RGD:1600115 |
ENSEMBL |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
ISO |
3 |
148,027,235 |
148,046,352 |
RGD:1624291 |
RGD |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
ISO |
3 |
148,027,235 |
148,046,352 |
RGD:1624291 |
RGD |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
ISO |
3 |
148,027,235 |
148,046,352 |
RGD:1624291 |
RGD |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
IEA |
3 |
148,027,235 |
148,046,352 |
RGD:1600115 |
ENSEMBL |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
IEA |
3 |
148,027,235 |
148,046,352 |
RGD:1600115 |
ENSEMBL |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
|
ISO |
4 |
84,135,530 |
84,148,503 |
RGD:1624291 |
RGD |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
|
ISO |
4 |
84,135,530 |
84,148,503 |
RGD:1624291 |
RGD |
| G |
Gipr |
gastric inhibitory polypeptide receptor |
|
|
IMP |
1 |
78,515,051 |
78,526,160 |
RGD:2312607 |
RGD |
| G |
Gnas |
GNAS complex locus |
|
|
IMP |
3 |
165,213,399 |
165,214,551 |
RGD:5509804 |
RGD |
| G |
Gpr65 |
G-protein coupled receptor 65 |
|
|
IEA |
6 |
122,432,615 |
122,433,628 |
RGD:1600115 |
ENSEMBL |
| G |
Gpr65 |
G-protein coupled receptor 65 |
|
|
ISO |
6 |
122,432,615 |
122,433,628 |
RGD:1624291 |
RGD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
|
ISO |
1 |
80,505,517 |
80,514,139 |
RGD:1624291 |
RGD |
| G |
Gsk3a |
glycogen synthase kinase 3 alpha |
|
|
IEA |
1 |
80,505,517 |
80,514,139 |
RGD:1600115 |
ENSEMBL |
| G |
Insl3 |
insulin-like 3 |
|
|
IDA |
16 |
18,890,131 |
18,891,475 |
RGD:633070 |
RGD |
| G |
Mc2r |
melanocortin 2 receptor (adrenocorticotropic hormone) |
|
|
ISO |
18 |
64,591,344 |
64,601,883 |
RGD:1624291 |
RGD |
| G |
Mc2r |
melanocortin 2 receptor (adrenocorticotropic hormone) |
|
|
IEA |
18 |
64,591,344 |
64,601,883 |
RGD:1600115 |
ENSEMBL |
| G |
Mc3r |
melanocortin 3 receptor |
|
|
ISO |
3 |
163,158,776 |
163,159,873 |
RGD:1624291 |
RGD |
| G |
Mc3r |
melanocortin 3 receptor |
|
|
ISO |
3 |
163,158,776 |
163,159,873 |
RGD:1624291 |
RGD |
| G |
Mc3r |
melanocortin 3 receptor |
|
|
IEA |
3 |
163,158,776 |
163,159,873 |
RGD:1600115 |
ENSEMBL |
| G |
Mc4r |
melanocortin 4 receptor |
|
|
ISO |
18 |
63,390,922 |
63,392,809 |
RGD:1624291 |
RGD |
| G |
Mc4r |
melanocortin 4 receptor |
|
|
ISO |
18 |
63,390,922 |
63,392,809 |
RGD:1624291 |
RGD |
| G |
Mc4r |
melanocortin 4 receptor |
|
|
IEA |
18 |
63,390,922 |
63,392,809 |
RGD:1600115 |
ENSEMBL |
| G |
Mc5r |
melanocortin 5 receptor |
|
|
ISO |
18 |
64,679,384 |
64,680,417 |
RGD:1624291 |
RGD |
| G |
Mc5r |
melanocortin 5 receptor |
|
|
IEA |
18 |
64,679,384 |
64,680,417 |
RGD:1600115 |
ENSEMBL |
| G |
Mrap |
melanocortin 2 receptor accessory protein |
|
|
IEA |
11 |
30,720,783 |
30,731,275 |
RGD:1600115 |
ENSEMBL |
| G |
Mrap |
melanocortin 2 receptor accessory protein |
|
|
ISO |
11 |
30,720,783 |
30,731,275 |
RGD:1624291 |
RGD |
| G |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
|
|
IEA |
8 |
92,385,844 |
92,442,482 |
RGD:1600115 |
ENSEMBL |
| G |
Mrap2 |
melanocortin 2 receptor accessory protein 2 |
|
|
ISO |
8 |
92,385,844 |
92,442,482 |
RGD:1624291 |
RGD |
| G |
Nme2 |
NME/NM23 nucleoside diphosphate kinase 2 |
|
|
IMP |
10 |
82,582,766 |
82,588,269 |
RGD:2299078 |
RGD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
|
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:1624291 |
RGD |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
|
IEA |
1 |
77,234,538 |
77,236,921 |
RGD:1600115 |
ENSEMBL |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
|
IEA |
1 |
77,234,538 |
77,236,921 |
RGD:1600115 |
ENSEMBL |
| G |
Ptgir |
prostaglandin I2 (prostacyclin) receptor (IP) |
|
|
ISO |
1 |
77,234,538 |
77,236,921 |
RGD:1624291 |
RGD |
| G |
Pth |
parathyroid hormone |
|
|
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:1624291 |
RGD |
| G |
Pth |
parathyroid hormone |
|
|
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:1624291 |
RGD |
| G |
Pth |
parathyroid hormone |
|
|
IEA |
1 |
171,240,596 |
171,243,528 |
RGD:1600115 |
ENSEMBL |
| G |
Pth |
parathyroid hormone |
|
|
IEA |
1 |
171,240,596 |
171,243,528 |
RGD:1600115 |
ENSEMBL |
| G |
Pthlh |
parathyroid hormone-like hormone |
|
|
ISO |
4 |
184,887,702 |
184,898,841 |
RGD:1624291 |
RGD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
|
ISO |
9 |
90,402,493 |
90,450,038 |
RGD:1624291 |
RGD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
|
ISO |
9 |
90,402,493 |
90,450,038 |
RGD:1624291 |
RGD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
|
IEA |
9 |
90,402,493 |
90,450,038 |
RGD:1600115 |
ENSEMBL |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
|
ISO |
10 |
90,275,463 |
90,277,242 |
RGD:1624291 |
RGD |
| G |
Ramp2 |
receptor (G protein-coupled) activity modifying protein 2 |
|
|
ISS |
10 |
90,275,463 |
90,277,242 |
RGD:1600115 |
UniProtKB |
| G |
Rxfp2 |
relaxin/insulin-like family peptide receptor 2 |
|
|
IDA |
12 |
5,326,997 |
5,388,674 |
RGD:1600172 |
RGD |
| G |
Ucn |
urocortin |
|
|
IDA |
6 |
25,216,788 |
25,217,618 |
RGD:70047 |
RGD |
positive regulation of cAMP metabolic process
|
| G |
Chga |
chromogranin A (parathyroid secretory protein 1) |
|
|
IDA |
|
|
|
RGD:6906968 |
RGD |
| G |
Crhr2 |
corticotropin releasing hormone receptor 2 |
|
|
IMP |
4 |
83,839,822 |
83,867,017 |
RGD:5131269 |
RGD |
| G |
Ghrh |
growth hormone releasing hormone |
|
|
IDA |
3 |
148,027,235 |
148,046,352 |
RGD:1624957 |
RGD |
| G |
Ghrhr |
growth hormone releasing hormone receptor |
|
|
IDA |
4 |
84,135,530 |
84,148,503 |
RGD:1624951 |
RGD |
| G |
Gpr3 |
G protein-coupled receptor 3 |
|
|
IDA |
5 |
151,915,723 |
151,916,688 |
RGD:632931 |
RGD |
| G |
Htr4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
|
IEA |
18 |
58,417,163 |
58,468,888 |
RGD:1600115 |
InterPro |
| G |
Htr6 |
5-hydroxytryptamine (serotonin) receptor 6, G protein-coupled |
|
|
IEA |
|
|
|
RGD:1600115 |
InterPro |
| G |
Htr7 |
5-hydroxytryptamine (serotonin) receptor 7, adenylate cyclase-coupled |
|
|
IEA |
1 |
240,136,279 |
240,260,620 |
RGD:1600115 |
InterPro |
positive regulation of cardiolipin metabolic process
|
| G |
Stoml2 |
stomatin (Epb7.2)-like 2 |
|
|
ISS |
5 |
59,518,467 |
59,522,064 |
RGD:1600115 |
UniProtKB |
| G |
Stoml2 |
stomatin (Epb7.2)-like 2 |
|
|
ISO |
5 |
59,518,467 |
59,522,064 |
RGD:1624291 |
RGD |
positive regulation of cellular glucuronidation
|
| G |
Prkce |
protein kinase C, epsilon |
|
|
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:1624291 |
RGD |
| G |
Prkce |
protein kinase C, epsilon |
|
|
IEA |
6 |
9,631,234 |
10,097,311 |
RGD:1600115 |
ENSEMBL |
positive regulation of ceramide biosynthetic process
|
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
|
ISO |
2 |
243,824,303 |
243,827,262 |
RGD:1624291 |
RGD |
| G |
Cyr61 |
cysteine-rich, angiogenic inducer, 61 |
|
|
IEA |
2 |
243,824,303 |
243,827,262 |
RGD:1600115 |
ENSEMBL |
| G |
Pla2g6 |
phospholipase A2, group VI (cytosolic, calcium-independent) |
|
|
IDA |
7 |
117,266,784 |
117,307,172 |
RGD:6482750 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:1624291 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
IEA |
16 |
5,954,218 |
5,975,743 |
RGD:1600115 |
ENSEMBL |
positive regulation of cGMP biosynthetic process
|
| G |
Adnp |
activity-dependent neuroprotector homeobox |
|
|
IDA |
3 |
159,345,280 |
159,355,067 |
RGD:1358228 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:1624291 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
IEA |
10 |
48,421,592 |
48,437,967 |
RGD:1600115 |
ENSEMBL |
| G |
Apoe |
apolipoprotein E |
|
|
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:1624291 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
IEA |
1 |
79,003,634 |
79,006,387 |
RGD:1600115 |
ENSEMBL |
| G |
Guca1a |
guanylate cyclase activator 1a (retina) |
|
|
IDA |
9 |
9,046,617 |
9,056,984 |
RGD:1599357 |
RGD |
| G |
Gucy1a2 |
guanylate cyclase 1, soluble, alpha 2 |
|
|
ISO |
8 |
113,253 |
262,544 |
RGD:1624291 |
RGD |
| G |
Gucy1a2 |
guanylate cyclase 1, soluble, alpha 2 |
|
|
IEA |
8 |
113,253 |
262,544 |
RGD:1600115 |
ENSEMBL |
| G |
Gucy1a3 |
guanylate cyclase 1, soluble, alpha 3 |
|
|
ISO |
2 |
173,756,824 |
173,818,316 |
RGD:1624291 |
RGD |
| G |
Gucy1a3 |
guanylate cyclase 1, soluble, alpha 3 |
|
|
IEA |
2 |
173,756,824 |
173,818,316 |
RGD:1600115 |
ENSEMBL |
| G |
Mtnr1a |
melatonin receptor 1A |
|
|
ISO |
16 |
50,439,407 |
50,458,585 |
RGD:1624291 |
RGD |
| G |
Mtnr1a |
melatonin receptor 1A |
|
|
IEA |
16 |
50,439,407 |
50,458,585 |
RGD:1600115 |
ENSEMBL |
| G |
Nppc |
natriuretic peptide C |
|
|
IDA |
9 |
85,434,254 |
85,438,454 |
RGD:1580115 |
RGD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
|
IMP |
2 |
182,724,916 |
182,740,242 |
RGD:729265 |
RGD |
| G |
Npr1 |
natriuretic peptide receptor A/guanylate cyclase A (atrionatriuretic peptide receptor A) |
|
|
IMP |
2 |
182,724,916 |
182,740,242 |
RGD:729410 |
RGD |
| G |
Ostn |
osteocrin |
|
|
ISO |
11 |
75,432,572 |
75,455,380 |
RGD:1624291 |
RGD |
| G |
Ostn |
osteocrin |
|
|
IEA |
11 |
75,432,572 |
75,455,380 |
RGD:1600115 |
ENSEMBL |
| G |
Rundc3a |
RUN domain containing 3A |
|
|
IDA |
10 |
91,501,018 |
91,510,151 |
RGD:1299631 |
RGD |
positive regulation of cGMP metabolic process
|
| G |
Fzd2 |
frizzled family receptor 2 |
|
|
ISO |
10 |
91,709,222 |
91,711,132 |
RGD:1624291 |
RGD |
| G |
Fzd2 |
frizzled family receptor 2 |
|
|
IEA |
10 |
91,709,222 |
91,711,132 |
RGD:1600115 |
ENSEMBL |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
ISO |
16 |
3,782,025 |
3,799,625 |
RGD:1624291 |
RGD |
| G |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
|
|
IEA |
16 |
3,782,025 |
3,799,625 |
RGD:1600115 |
ENSEMBL |
positive regulation of cholesterol biosynthetic process
|
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
|
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:1624291 |
RGD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
|
IEA |
20 |
9,390,485 |
9,459,574 |
RGD:1600115 |
ENSEMBL |
| G |
Fdps |
farnesyl diphosphate synthase |
|
|
IMP |
2 |
181,138,474 |
181,177,903 |
RGD:2316295 |
RGD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
ISO |
18 |
31,785,480 |
31,806,452 |
RGD:1624291 |
RGD |
| G |
Fgf1 |
fibroblast growth factor 1 (acidic) |
|
|
ISS |
18 |
31,785,480 |
31,806,452 |
RGD:1600115 |
UniProtKB |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
IMP |
12 |
22,078,629 |
22,097,301 |
RGD:2316785 |
RGD |
| G |
Sec14l2 |
SEC14-like 2 (S. cerevisiae) |
|
|
IDA |
14 |
84,728,484 |
84,748,418 |
RGD:727312 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
IEA |
10 |
46,461,684 |
46,483,646 |
RGD:1600115 |
ENSEMBL |
positive regulation of cholesterol esterification
|
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:1624291 |
RGD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
IEA |
19 |
54,738,556 |
54,750,349 |
RGD:1600115 |
ENSEMBL |
| G |
Agtr1a |
angiotensin II receptor, type 1a |
|
|
ISO |
17 |
40,629,318 |
40,684,982 |
RGD:1624291 |
RGD |
| G |
Agtr1b |
angiotensin II receptor, type 1b |
|
|
ISO |
2 |
105,503,269 |
105,602,591 |
RGD:2290270 |
MGI |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Apoa1 |
apolipoprotein A-I |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:1624291 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
IEA |
13 |
87,114,734 |
87,116,372 |
RGD:1600115 |
ENSEMBL |
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:1624291 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:1624291 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
ISO |
1 |
79,003,634 |
79,006,387 |
RGD:1624291 |
RGD |
| G |
Apoe |
apolipoprotein E |
|
|
IEA |
1 |
79,003,634 |
79,006,387 |
RGD:1600115 |
ENSEMBL |
positive regulation of cortisol biosynthetic process
|
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
ISO |
5 |
156,064,371 |
156,083,198 |
RGD:1624291 |
RGD |
| G |
Wnt4 |
wingless-type MMTV integration site family, member 4 |
|
|
IEA |
5 |
156,064,371 |
156,083,198 |
RGD:1600115 |
ENSEMBL |
positive regulation of cyclic nucleotide metabolic process
|
| G |
Calm1 |
calmodulin 1 |
|
|
ISO |
6 |
124,477,601 |
124,485,669 |
RGD:1624291 |
RGD |
| G |
Calm2 |
calmodulin 2 |
|
|
ISO |
6 |
64,161,641 |
64,162,751 |
RGD:1624291 |
RGD |
| G |
Calm3 |
calmodulin 3 |
|
|
ISO |
1 |
77,245,609 |
77,252,717 |
RGD:1624291 |
RGD |
positive regulation of diacylglycerol biosynthetic process
|
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
|
IEA |
15 |
55,463,743 |
55,532,293 |
RGD:1600115 |
InterPro |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
|
IEA |
9 |
84,840,026 |
84,852,984 |
RGD:1600115 |
InterPro |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
|
IEA |
X |
31,012,921 |
31,244,127 |
RGD:1600115 |
InterPro |
positive regulation of fatty acid beta-oxidation
|
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
|
IEA |
7 |
129,542,758 |
129,591,363 |
RGD:1600115 |
ENSEMBL |
| G |
Abcd2 |
ATP-binding cassette, subfamily D (ALD), member 2 |
|
|
ISO |
7 |
129,542,758 |
129,591,363 |
RGD:1624291 |
RGD |
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
|
IGI |
1 |
261,554,383 |
261,599,373 |
RGD:2312802 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:1624291 |
RGD |
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
|
IMP |
1 |
205,852,800 |
205,912,972 |
RGD:2311346 |
RGD |
| G |
Fabp1 |
fatty acid binding protein 1, liver |
|
|
IDA |
4 |
104,412,200 |
104,415,981 |
RGD:1626442 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IEA |
9 |
81,585,251 |
81,638,071 |
RGD:1600115 |
ENSEMBL |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:1624291 |
RGD |
| G |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
|
|
ISO |
6 |
52,605,869 |
52,607,863 |
RGD:1624291 |
RGD |
| G |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
|
|
IEA |
6 |
52,605,869 |
52,607,863 |
RGD:1600115 |
ENSEMBL |
positive regulation of fatty acid biosynthetic process
|
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
ISO |
19 |
54,738,556 |
54,750,349 |
RGD:1624291 |
RGD |
| G |
Agt |
angiotensinogen (serpin peptidase inhibitor, clade A, member 8) |
|
|
IEA |
19 |
54,738,556 |
54,750,349 |
RGD:1600115 |
ENSEMBL |
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:1624291 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISO |
8 |
49,253,538 |
49,255,777 |
RGD:1624291 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
IEA |
8 |
49,253,538 |
49,255,777 |
RGD:1600115 |
ENSEMBL |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:1624291 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
IEA |
1 |
78,979,034 |
78,984,002 |
RGD:1600115 |
ENSEMBL |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
IMP |
3 |
154,459,863 |
154,482,825 |
RGD:1624995 |
RGD |
| G |
Mid1ip1 |
MID1 interacting protein 1 |
|
|
ISO |
X |
24,205,679 |
24,207,860 |
RGD:1624291 |
RGD |
| G |
Mid1ip1 |
MID1 interacting protein 1 |
|
|
ISS |
X |
24,205,679 |
24,207,860 |
RGD:1600115 |
UniProtKB |
| G |
Mlxipl |
MLX interacting protein-like |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
|
ISO |
1 |
95,027,197 |
95,032,516 |
RGD:1624291 |
RGD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
|
IEA |
1 |
95,027,197 |
95,032,516 |
RGD:1600115 |
ENSEMBL |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
|
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:1624291 |
RGD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
|
IEA |
3 |
75,542,211 |
75,550,793 |
RGD:1600115 |
ENSEMBL |
positive regulation of fatty acid metabolic process
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:1624291 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:1600115 |
UniProtKB |
| G |
Ghsr |
growth hormone secretagogue receptor |
|
|
IMP |
2 |
113,269,623 |
113,272,999 |
RGD:625699 |
RGD |
positive regulation of fatty acid oxidation
|
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
|
ISO |
10 |
28,571,051 |
28,588,714 |
RGD:1624291 |
RGD |
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
|
IEA |
10 |
28,571,051 |
28,588,714 |
RGD:1600115 |
ENSEMBL |
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
|
ISO |
19 |
49,637,193 |
49,653,016 |
RGD:1624291 |
RGD |
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
|
IEA |
19 |
49,637,193 |
49,653,016 |
RGD:1600115 |
ENSEMBL |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:1624291 |
RGD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
IEA |
7 |
123,729,774 |
123,807,090 |
RGD:1600115 |
ENSEMBL |
| G |
Pparg |
peroxisome proliferator-activated receptor gamma |
|
|
IMP |
4 |
151,492,220 |
151,617,331 |
RGD:2301882 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IMP |
14 |
64,278,115 |
64,370,912 |
RGD:1601466 |
RGD |
| G |
Ppargc1a |
peroxisome proliferator-activated receptor gamma, coactivator 1 alpha |
|
|
IMP |
14 |
64,278,115 |
64,370,912 |
RGD:7241851 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
NAS |
2 |
54,327,821 |
54,360,462 |
RGD:727370 |
UniProtKB |
positive regulation of glucokinase activity
|
| G |
Bad |
BCL2-associated agonist of cell death |
|
|
ISO |
1 |
209,617,373 |
209,626,292 |
RGD:1624291 |
RGD |
| G |
Bad |
BCL2-associated agonist of cell death |
|
|
ISS |
1 |
209,617,373 |
209,626,292 |
RGD:1600115 |
UniProtKB |
| G |
Dusp12 |
dual specificity phosphatase 12 |
|
|
IDA |
13 |
86,737,093 |
86,746,186 |
RGD:68242 |
RGD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Gckr |
glucokinase (hexokinase 4) regulator |
|
|
IEA |
|
|
|
RGD:1600115 |
ENSEMBL |
| G |
Pfkfb1 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 1 |
|
|
IMP |
X |
39,838,471 |
39,886,071 |
RGD:2302684 |
RGD |
| G |
Pfkfb2 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 2 |
|
|
IDA |
13 |
43,624,838 |
43,652,660 |
RGD:2304071 |
RGD |
positive regulation of gluconeogenesis
|
| G |
Arpp19 |
cAMP-regulated phosphoprotein 19 |
|
|
ISO |
8 |
79,824,737 |
79,846,702 |
RGD:1624291 |
RGD |
| G |
Foxo1 |
forkhead box O1 |
|
|
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:1624291 |
RGD |
| G |
Foxo1 |
forkhead box O1 |
|
|
IEA |
2 |
141,127,345 |
141,203,446 |
RGD:1600115 |
ENSEMBL |
| G |
Hnf4a |
hepatocyte nuclear factor 4, alpha |
|
|
IMP |
3 |
154,459,863 |
154,482,825 |
RGD:1624992 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
NAS |
2 |
54,327,821 |
54,360,462 |
|
UniProtKB |
| G |
Smek2 |
SMEK homolog 2, suppressor of mek1 (Dictyostelium) |
|
|
IEA |
14 |
110,170,267 |
110,219,298 |
RGD:1600115 |
ENSEMBL |
| G |
Smek2 |
SMEK homolog 2, suppressor of mek1 (Dictyostelium) |
|
|
ISO |
14 |
110,170,267 |
110,219,298 |
RGD:1624291 |
RGD |
| G |
Stk11 |
serine/threonine kinase 11 |
|
|
IMP |
7 |
11,086,760 |
11,103,522 |
RGD:2291956 |
RGD |
positive regulation of glucose metabolic process
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISS |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
UniProtKB |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:1624291 |
RGD |
| G |
LOC259246 |
alpha-2u globulin PGCL1 |
|
|
ISS |
5 |
78,707,324 |
78,710,745 |
RGD:1600115 |
UniProtKB |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
|
ISO |
18 |
62,914,845 |
62,918,832 |
RGD:1624291 |
RGD |
| G |
Pmaip1 |
phorbol-12-myristate-13-acetate-induced protein 1 |
|
|
IEA |
18 |
62,914,845 |
62,918,832 |
RGD:1600115 |
ENSEMBL |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IMP |
3 |
148,157,256 |
148,170,524 |
RGD:2307340 |
RGD |
positive regulation of glucosylceramide catabolic process
|
| G |
Prkcd |
protein kinase C, delta |
|
|
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:1624291 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
IEA |
16 |
5,954,218 |
5,975,743 |
RGD:1600115 |
ENSEMBL |
positive regulation of glutamate metabolic process
|
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
|
ISO |
7 |
26,189,759 |
26,307,061 |
RGD:1624291 |
RGD |
positive regulation of glycogen biosynthetic process
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IEA |
6 |
137,640,482 |
137,657,552 |
RGD:1600115 |
ENSEMBL |
| G |
Akt2 |
v-akt murine thymoma viral oncogene homolog 2 |
|
|
ISO |
1 |
82,686,233 |
82,726,544 |
RGD:1624291 |
RGD |
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
|
ISO |
10 |
28,571,051 |
28,588,714 |
RGD:1624291 |
RGD |
| G |
C1qtnf2 |
C1q and tumor necrosis factor related protein 2 |
|
|
IEA |
10 |
28,571,051 |
28,588,714 |
RGD:1600115 |
ENSEMBL |
| G |
Dyrk2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
|
|
ISO |
7 |
58,114,127 |
58,126,547 |
RGD:1624291 |
RGD |
| G |
Dyrk2 |
dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 |
|
|
IEA |
7 |
58,114,127 |
58,126,547 |
RGD:1600115 |
ENSEMBL |
| G |
Gck |
glucokinase |
|
|
ISO |
14 |
86,572,518 |
86,587,723 |
RGD:1624291 |
RGD |
| G |
Gck |
glucokinase |
|
|
ISS |
14 |
86,572,518 |
86,587,723 |
RGD:1600115 |
UniProtKB |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:1624291 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IEA |
7 |
24,531,669 |
24,605,742 |
RGD:1600115 |
ENSEMBL |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISS |
7 |
24,531,669 |
24,605,742 |
RGD:1600115 |
UniProtKB |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
ISO |
1 |
202,906,624 |
202,915,231 |
RGD:1624291 |
RGD |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IEA |
1 |
202,906,624 |
202,915,231 |
RGD:1600115 |
ENSEMBL |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IEA |
12 |
2,934,967 |
3,087,691 |
RGD:1600115 |
ENSEMBL |
| G |
Insr |
insulin receptor |
|
|
IEA |
12 |
2,934,967 |
3,087,691 |
RGD:1600115 |
ENSEMBL |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IEA |
9 |
81,585,251 |
81,638,071 |
RGD:1600115 |
ENSEMBL |
| G |
Irs2 |
insulin receptor substrate 2 |
|
|
ISO |
16 |
83,379,987 |
83,404,220 |
RGD:1624291 |
RGD |
| G |
Ppp1r3g |
protein phosphatase 1, regulatory subunit 3G |
|
|
ISO |
17 |
35,177,316 |
35,178,359 |
RGD:1624291 |
RGD |
| G |
Pth |
parathyroid hormone |
|
|
ISO |
1 |
171,240,596 |
171,243,528 |
RGD:1624291 |
RGD |
| G |
Pth |
parathyroid hormone |
|
|
ISS |
1 |
171,240,596 |
171,243,528 |
RGD:1600115 |
UniProtKB |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
|
ISO |
1 |
245,419,532 |
245,527,846 |
RGD:1624291 |
RGD |
positive regulation of glycogen catabolic process
|
| G |
Adra1b |
adrenoceptor alpha 1B |
|
|
ISO |
10 |
28,889,092 |
28,946,889 |
RGD:1624291 |
RGD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
|
NAS |
7 |
62,225,537 |
62,229,461 |
RGD:1298691 |
UniProtKB |
| G |
Hmgb1 |
high mobility group box 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
positive regulation of glycolysis
|
| G |
Gck |
glucokinase |
|
|
IDA |
14 |
86,572,518 |
86,587,723 |
RGD:2301905 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
ISO |
7 |
24,531,669 |
24,605,742 |
RGD:1624291 |
RGD |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IEA |
7 |
24,531,669 |
24,605,742 |
RGD:1600115 |
ENSEMBL |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
ISO |
12 |
2,934,967 |
3,087,691 |
RGD:1624291 |
RGD |
| G |
Insr |
insulin receptor |
|
|
IEA |
12 |
2,934,967 |
3,087,691 |
RGD:1600115 |
ENSEMBL |
| G |
Mif |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
|
|
IMP |
20 |
13,191,986 |
13,192,851 |
RGD:1642010 |
RGD |
| G |
Mlxipl |
MLX interacting protein-like |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Mlxipl |
MLX interacting protein-like |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Myc |
myelocytomatosis oncogene |
|
|
IMP |
7 |
98,953,142 |
98,958,060 |
RGD:7207891 |
RGD |
| G |
Prkaa1 |
protein kinase, AMP-activated, alpha 1 catalytic subunit |
|
|
IDA |
2 |
54,327,821 |
54,360,462 |
|
UniProtKB |
| G |
Prkaa2 |
protein kinase, AMP-activated, alpha 2 catalytic subunit |
|
|
IDA |
5 |
126,007,672 |
126,074,012 |
|
UniProtKB |
positive regulation of guanylate cyclase activity
|
| G |
Adora2b |
adenosine A2B receptor |
|
|
ISO |
10 |
48,421,592 |
48,437,967 |
RGD:1624291 |
RGD |
| G |
Adora2b |
adenosine A2B receptor |
|
|
IEA |
10 |
48,421,592 |
48,437,967 |
RGD:1600115 |
ENSEMBL |
| G |
Guca1a |
guanylate cyclase activator 1a (retina) |
|
|
IDA |
9 |
9,046,617 |
9,056,984 |
RGD:1599357 |
RGD |
| G |
Guca1a |
guanylate cyclase activator 1a (retina) |
|
|
ISO |
9 |
9,046,617 |
9,056,984 |
RGD:1624291 |
RGD |
| G |
Guca1b |
guanylate cyclase activator 1B |
|
|
ISO |
9 |
9,058,038 |
9,065,831 |
RGD:1624291 |
RGD |
| G |
Guca2a |
guanylate cyclase activator 2a (guanylin) |
|
|
IDA |
5 |
140,227,304 |
140,229,146 |
RGD:731149 |
GOC |
| G |
Nos1 |
nitric oxide synthase 1, neuronal |
|
|
IBA |
12 |
39,812,500 |
39,869,484 |
RGD:1600115 |
RefGenome |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
ISO |
4 |
6,158,847 |
6,179,441 |
RGD:1624291 |
RGD |
| G |
Nos3 |
nitric oxide synthase 3, endothelial cell |
|
|
IBA |
4 |
6,158,847 |
6,179,441 |
RGD:1600115 |
RefGenome |
| G |
Rundc3a |
RUN domain containing 3A |
|
|
IDA |
10 |
91,501,018 |
91,510,151 |
RGD:1299631 |
GOC |
positive regulation of homocysteine metabolic process
|
| G |
Comt |
catechol-O-methyltransferase |
|
|
IMP |
11 |
84,561,591 |
84,581,713 |
RGD:2289784 |
RGD |
positive regulation of hyaluronan biosynthetic process
|
| G |
Egf |
epidermal growth factor |
|
|
ISO |
2 |
227,103,900 |
227,195,062 |
RGD:1624291 |
RGD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
|
ISO |
2 |
233,091,013 |
233,187,501 |
RGD:1624291 |
RGD |
| G |
Nfkb1 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
|
|
IEA |
2 |
233,091,013 |
233,187,501 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IEA |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISS |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
UniProtKB |
positive regulation of inositol phosphate biosynthetic process
|
| G |
Adcyap1r1 |
adenylate cyclase activating polypeptide 1 receptor 1 |
|
|
IDA |
4 |
84,209,729 |
84,254,982 |
RGD:2315982 |
RGD |
| G |
Mas1 |
MAS1 oncogene |
|
|
IDA |
1 |
42,154,786 |
42,185,750 |
RGD:2316794 |
RGD |
| G |
Pth1r |
parathyroid hormone 1 receptor |
|
|
IDA |
8 |
115,099,763 |
115,119,362 |
|
BHF-UCL |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:1624291 |
RGD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
IEA |
4 |
89,613,731 |
89,722,807 |
RGD:1600115 |
ENSEMBL |
positive regulation of inositol trisphosphate biosynthetic process
|
| G |
Htr2a |
5-hydroxytryptamine (serotonin) receptor 2A, G protein-coupled |
|
|
IEA |
15 |
55,463,743 |
55,532,293 |
RGD:1600115 |
InterPro |
| G |
Htr2b |
5-hydroxytryptamine (serotonin) receptor 2B, G protein-coupled |
|
|
IEA |
9 |
84,840,026 |
84,852,984 |
RGD:1600115 |
InterPro |
| G |
Htr2c |
5-hydroxytryptamine (serotonin) receptor 2C, G protein-coupled |
|
|
IEA |
X |
31,012,921 |
31,244,127 |
RGD:1600115 |
InterPro |
| G |
Lhcgr |
luteinizing hormone/choriogonadotropin receptor |
|
|
ISO |
6 |
12,613,622 |
12,651,587 |
RGD:1624291 |
RGD |
| G |
P2ry1 |
purinergic receptor P2Y, G-protein coupled, 1 |
|
|
IDA |
2 |
150,460,361 |
150,465,855 |
|
BHF-UCL |
| G |
Plcd1 |
phospholipase C, delta 1 |
|
|
IMP |
8 |
124,023,090 |
124,052,193 |
RGD:2300424 |
RGD |
| G |
Pou1f1 |
POU class 1 homeobox 1 |
|
|
ISO |
11 |
2,959,383 |
2,980,545 |
RGD:1624291 |
RGD |
| G |
Pou1f1 |
POU class 1 homeobox 1 |
|
|
IEA |
11 |
2,959,383 |
2,980,545 |
RGD:1600115 |
ENSEMBL |
positive regulation of lipid biosynthetic process
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
IEA |
6 |
137,640,482 |
137,657,552 |
RGD:1600115 |
ENSEMBL |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
|
ISO |
9 |
63,170,785 |
63,234,727 |
RGD:1624291 |
RGD |
| G |
Creb1 |
cAMP responsive element binding protein 1 |
|
|
ISS |
9 |
63,170,785 |
63,234,727 |
RGD:1600115 |
UniProtKB |
| G |
Crebl2 |
cAMP responsive element binding protein-like 2 |
|
|
ISO |
4 |
171,744,836 |
171,771,198 |
RGD:1624291 |
RGD |
| G |
Crebl2 |
cAMP responsive element binding protein-like 2 |
|
|
ISS |
4 |
171,744,836 |
171,771,198 |
RGD:1600115 |
UniProtKB |
| G |
Dbi |
diazepam binding inhibitor (GABA receptor modulator, acyl-CoA binding protein) |
|
|
IDA |
|
|
|
RGD:2316274 |
RGD |
| G |
Mlxipl |
MLX interacting protein-like |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
ISO |
5 |
165,531,402 |
165,640,899 |
RGD:1624291 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
ISS |
5 |
165,531,402 |
165,640,899 |
RGD:1600115 |
UniProtKB |
| G |
Nt5e |
5' nucleotidase, ecto |
|
|
IEP |
8 |
93,591,630 |
93,635,481 |
RGD:5134347 |
RGD |
| G |
Sorbs1 |
sorbin and SH3 domain containing 1 |
|
|
ISO |
1 |
245,419,532 |
245,527,846 |
RGD:1624291 |
RGD |
positive regulation of lipid catabolic process
|
| G |
Angptl3 |
angiopoietin-like 3 |
|
|
ISO |
5 |
119,479,669 |
119,484,358 |
RGD:1624291 |
RGD |
| G |
Angptl3 |
angiopoietin-like 3 |
|
|
IEA |
5 |
119,479,669 |
119,484,358 |
RGD:1600115 |
ENSEMBL |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
ISO |
13 |
87,114,734 |
87,116,372 |
RGD:1624291 |
RGD |
| G |
Apoa2 |
apolipoprotein A-II |
|
|
IEA |
13 |
87,114,734 |
87,116,372 |
RGD:1600115 |
ENSEMBL |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISO |
8 |
49,253,538 |
49,255,777 |
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
ISO |
3 |
116,964,422 |
116,970,867 |
RGD:1624291 |
RGD |
| G |
Il1b |
interleukin 1 beta |
|
|
IEA |
3 |
116,964,422 |
116,970,867 |
RGD:1600115 |
ENSEMBL |
| G |
Prkce |
protein kinase C, epsilon |
|
|
ISO |
6 |
9,631,234 |
10,097,311 |
RGD:1624291 |
RGD |
| G |
Prkce |
protein kinase C, epsilon |
|
|
IEA |
6 |
9,631,234 |
10,097,311 |
RGD:1600115 |
ENSEMBL |
positive regulation of lipid metabolic process
|
| G |
LOC259246 |
alpha-2u globulin PGCL1 |
|
|
ISS |
5 |
78,707,324 |
78,710,745 |
RGD:1600115 |
UniProtKB |
positive regulation of phosphatidylcholine biosynthetic process
|
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
|
ISO |
9 |
78,083,239 |
78,106,933 |
RGD:1624291 |
RGD |
| G |
Acsl3 |
acyl-CoA synthetase long-chain family member 3 |
|
|
IEA |
9 |
78,083,239 |
78,106,933 |
RGD:1600115 |
ENSEMBL |
positive regulation of phosphatidylinositol 3-kinase activity
|
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
|
IEA |
5 |
59,221,738 |
59,223,682 |
RGD:1600115 |
ENSEMBL |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
|
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:1624291 |
RGD |
| G |
Ccl19 |
chemokine (C-C motif) ligand 19 |
|
|
ISO |
5 |
59,221,738 |
59,223,682 |
RGD:1624291 |
RGD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
|
ISO |
5 |
59,238,897 |
59,240,001 |
RGD:1624291 |
RGD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
|
ISO |
5 |
59,238,897 |
59,240,001 |
RGD:1624291 |
RGD |
| G |
Ccl21 |
chemokine (C-C motif) ligand 21 |
|
|
IEA |
5 |
59,238,897 |
59,240,001 |
RGD:1600115 |
ENSEMBL |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
|
ISO |
5 |
156,106,123 |
156,143,040 |
RGD:1624291 |
RGD |
| G |
Cdc42 |
cell division cycle 42 (GTP binding protein) |
|
|
IEA |
5 |
156,106,123 |
156,143,040 |
RGD:1600115 |
ENSEMBL |
| G |
Epha8 |
Eph receptor A8 |
|
|
ISO |
5 |
155,696,393 |
155,717,598 |
RGD:1624291 |
RGD |
| G |
Epha8 |
Eph receptor A8 |
|
|
IEA |
5 |
155,696,393 |
155,717,598 |
RGD:1600115 |
ENSEMBL |
| G |
Epha8 |
Eph receptor A8 |
|
|
ISS |
5 |
155,696,393 |
155,717,598 |
RGD:1600115 |
UniProtKB |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
NOT |
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:1624291 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISO |
9 |
66,843,898 |
67,967,970 |
RGD:1624291 |
RGD |
| G |
Erbb4 |
v-erb-a erythroblastic leukemia viral oncogene homolog 4 (avian) |
|
|
ISS |
9 |
66,843,898 |
67,967,970 |
RGD:1600115 |
UniProtKB |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
ISO |
2 |
123,893,314 |
123,947,136 |
RGD:1624291 |
RGD |
| G |
Fgf2 |
fibroblast growth factor 2 |
|
|
IEA |
2 |
123,893,314 |
123,947,136 |
RGD:1600115 |
ENSEMBL |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
ISO |
14 |
82,683,191 |
82,697,229 |
RGD:1624291 |
RGD |
| G |
Fgfr3 |
fibroblast growth factor receptor 3 |
|
|
IEA |
14 |
82,683,191 |
82,697,229 |
RGD:1600115 |
ENSEMBL |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
|
ISO |
5 |
152,119,455 |
152,147,057 |
RGD:1624291 |
RGD |
| G |
Fgr |
Gardner-Rasheed feline sarcoma viral (v-fgr) oncogene homolog |
|
|
IEA |
5 |
152,119,455 |
152,147,057 |
RGD:1600115 |
ENSEMBL |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
|
ISO |
12 |
7,858,092 |
8,035,966 |
RGD:1624291 |
RGD |
| G |
Flt1 |
FMS-related tyrosine kinase 1 |
|
|
IEA |
12 |
7,858,092 |
8,035,966 |
RGD:1600115 |
ENSEMBL |
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
| G |
Ins2 |
insulin 2 |
|
|
IEA |
1 |
202,935,548 |
202,936,379 |
RGD:1600115 |
ENSEMBL |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
ISO |
9 |
81,585,251 |
81,638,071 |
RGD:1624291 |
RGD |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IEA |
9 |
81,585,251 |
81,638,071 |
RGD:1600115 |
ENSEMBL |
| G |
Irs1 |
insulin receptor substrate 1 |
|
|
IDA |
9 |
81,585,251 |
81,638,071 |
|
UniProtKB |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
ISO |
5 |
16,933,111 |
17,054,564 |
RGD:1624291 |
RGD |
| G |
Lyn |
v-yes-1 Yamaguchi sarcoma viral related oncogene homolog |
|
|
IEA |
5 |
16,933,111 |
17,054,564 |
RGD:1600115 |
ENSEMBL |
| G |
Nod2 |
nucleotide-binding oligomerization domain containing 2 |
|
|
ISO |
19 |
19,662,337 |
19,697,341 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISO |
7 |
118,244,385 |
118,262,021 |
RGD:1624291 |
RGD |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
IEA |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfb |
platelet-derived growth factor beta polypeptide |
|
|
ISS |
7 |
118,244,385 |
118,262,021 |
RGD:1600115 |
UniProtKB |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISO |
14 |
35,369,422 |
35,418,126 |
RGD:1624291 |
RGD |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
IEA |
14 |
35,369,422 |
35,418,126 |
RGD:1600115 |
ENSEMBL |
| G |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
|
|
ISS |
14 |
35,369,422 |
35,418,126 |
RGD:1600115 |
UniProtKB |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISO |
18 |
57,014,475 |
57,053,581 |
RGD:1624291 |
RGD |
| G |
Pdgfrb |
platelet derived growth factor receptor, beta polypeptide |
|
|
ISS |
18 |
57,014,475 |
57,053,581 |
RGD:1600115 |
UniProtKB |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISS |
15 |
45,589,222 |
45,717,866 |
RGD:1600115 |
UniProtKB |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:1624291 |
RGD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
|
ISO |
12 |
11,380,314 |
11,400,531 |
RGD:1624291 |
RGD |
| G |
Rac1 |
ras-related C3 botulinum toxin substrate 1 |
|
|
IEA |
12 |
11,380,314 |
11,400,531 |
RGD:1600115 |
ENSEMBL |
| G |
Src |
v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) |
|
|
IMP |
3 |
148,157,256 |
148,170,524 |
|
UniProtKB |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
|
ISO |
5 |
115,047,195 |
115,196,172 |
RGD:1624291 |
RGD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
|
ISO |
5 |
115,047,195 |
115,196,172 |
RGD:1624291 |
RGD |
| G |
Tek |
TEK tyrosine kinase, endothelial |
|
|
IEA |
5 |
115,047,195 |
115,196,172 |
RGD:1600115 |
ENSEMBL |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISO |
1 |
80,894,705 |
80,911,020 |
RGD:1624291 |
RGD |
| G |
Tgfb1 |
transforming growth factor, beta 1 |
|
|
ISS |
1 |
80,894,705 |
80,911,020 |
RGD:1600115 |
UniProtKB |
| G |
Vav2 |
vav 2 guanine nucleotide exchange factor |
|
|
ISO |
3 |
6,153,681 |
6,347,676 |
RGD:1624291 |
RGD |
| G |
Vav2 |
vav 2 guanine nucleotide exchange factor |
|
|
IEA |
3 |
6,153,681 |
6,347,676 |
RGD:1600115 |
ENSEMBL |
| G |
Vav3 |
vav 3 guanine nucleotide exchange factor |
|
|
ISO |
2 |
204,982,222 |
205,326,505 |
RGD:1624291 |
RGD |
positive regulation of phosphatidylinositol biosynthetic process
|
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
ISO |
12 |
21,805,746 |
21,812,711 |
RGD:1624291 |
RGD |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
IEA |
12 |
21,805,746 |
21,812,711 |
RGD:1600115 |
ENSEMBL |
| G |
Zp3 |
zona pellucida glycoprotein 3 (sperm receptor) |
|
|
ISS |
12 |
21,805,746 |
21,812,711 |
RGD:1600115 |
UniProtKB |
positive regulation of phospholipid catabolic process
|
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:1624291 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
IEA |
1 |
78,979,034 |
78,984,002 |
RGD:1600115 |
ENSEMBL |
positive regulation of prostaglandin biosynthetic process
|
| G |
Anxa1 |
annexin A1 |
|
|
IMP |
1 |
223,478,436 |
223,494,455 |
RGD:2306959 |
RGD |
| G |
Avp |
arginine vasopressin |
|
|
IMP |
3 |
118,205,007 |
118,206,985 |
RGD:2300349 |
RGD |
| G |
Avpr1a |
arginine vasopressin receptor 1A |
|
|
IMP |
7 |
62,225,537 |
62,229,461 |
RGD:2300349 |
RGD |
| G |
Mapk9 |
mitogen-activated protein kinase 9 |
|
|
IMP |
10 |
35,353,486 |
35,384,319 |
RGD:2304243 |
RGD |
| G |
Pla2g4a |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
|
|
IMP |
13 |
64,135,729 |
64,280,815 |
RGD:1642461 |
RGD |
positive regulation of protein glycosylation
|
| G |
Chp |
calcium binding protein p22 |
|
|
IDA |
3 |
106,066,389 |
106,101,635 |
|
UniProtKB |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
|
ISO |
9 |
90,402,493 |
90,450,038 |
RGD:1624291 |
RGD |
| G |
Ramp1 |
receptor (G protein-coupled) activity modifying protein 1 |
|
|
IEA |
9 |
90,402,493 |
90,450,038 |
RGD:1600115 |
ENSEMBL |
| G |
Slc51b |
solute carrier family 51, beta subunit |
|
|
IEA |
8 |
69,661,815 |
69,669,889 |
RGD:1600115 |
ENSEMBL |
| G |
Slc51b |
solute carrier family 51, beta subunit |
|
|
ISO |
8 |
69,661,815 |
69,669,889 |
RGD:1624291 |
RGD |
positive regulation of protein glycosylation in Golgi
|
| G |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
|
|
ISS |
5 |
8,498,644 |
8,592,918 |
RGD:1600115 |
UniProtKB |
| G |
Arfgef1 |
ADP-ribosylation factor guanine nucleotide-exchange factor 1(brefeldin A-inhibited) |
|
|
ISO |
5 |
8,498,644 |
8,592,918 |
RGD:1624291 |
RGD |
positive regulation of spermidine biosynthetic process
|
| G |
Paox |
polyamine oxidase (exo-N4-amino) |
|
|
IEA |
1 |
199,909,816 |
199,934,938 |
RGD:1600115 |
ENSEMBL |
| G |
Paox |
polyamine oxidase (exo-N4-amino) |
|
|
ISO |
1 |
199,909,816 |
199,934,938 |
RGD:1624291 |
RGD |
positive regulation of sphingomyelin catabolic process
|
| G |
Prkcd |
protein kinase C, delta |
|
|
ISO |
16 |
5,954,218 |
5,975,743 |
RGD:1624291 |
RGD |
| G |
Prkcd |
protein kinase C, delta |
|
|
IEA |
16 |
5,954,218 |
5,975,743 |
RGD:1600115 |
ENSEMBL |
positive regulation of steroid biosynthetic process
|
| G |
Adora2b |
adenosine A2B receptor |
|
|
IMP |
10 |
48,421,592 |
48,437,967 |
RGD:2316120 |
RGD |
| G |
Il1a |
interleukin 1 alpha |
|
|
IDA |
3 |
116,913,612 |
116,924,114 |
RGD:2311095 |
RGD |
| G |
Scp2 |
sterol carrier protein 2 |
|
|
IDA |
5 |
129,152,836 |
129,230,401 |
|
UniProtKB |
positive regulation of steroid hormone biosynthetic process
|
| G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
|
|
IMP |
1 |
251,965,458 |
251,971,449 |
RGD:4888510 |
RGD |
| G |
Gh1 |
growth hormone 1 |
|
|
IDA |
10 |
95,692,240 |
95,694,117 |
RGD:1600072 |
BHF-UCL |
| G |
Igf1 |
insulin-like growth factor 1 |
|
|
IDA |
7 |
24,531,669 |
24,605,742 |
RGD:1600072 |
BHF-UCL |
| G |
Igf1r |
insulin-like growth factor 1 receptor |
|
|
IMP |
1 |
122,704,976 |
122,990,007 |
RGD:1600072 |
BHF-UCL |
| G |
Igf2 |
insulin-like growth factor 2 |
|
|
IDA |
1 |
202,906,624 |
202,915,231 |
RGD:1600072 |
BHF-UCL |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
IDA |
12 |
22,078,629 |
22,097,301 |
RGD:4889602 |
RGD |
positive regulation of steroid metabolic process
|
| G |
Scp2 |
sterol carrier protein 2 |
|
|
ISO |
5 |
129,152,836 |
129,230,401 |
RGD:1624291 |
RGD |
positive regulation of thyroid hormone generation
|
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:1624291 |
RGD |
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISO |
17 |
79,991,587 |
80,011,574 |
RGD:1624291 |
RGD |
| G |
Gata3 |
GATA binding protein 3 |
|
|
ISS |
17 |
79,991,587 |
80,011,574 |
RGD:1600115 |
UniProtKB |
| G |
Hpn |
hepsin |
|
|
ISO |
1 |
86,145,615 |
86,161,091 |
RGD:1624291 |
RGD |
| G |
Hpn |
hepsin |
|
|
ISS |
1 |
86,145,615 |
86,161,091 |
RGD:1600115 |
UniProtKB |
| G |
Pax8 |
paired box 8 |
|
|
ISO |
3 |
2,671,478 |
2,726,801 |
RGD:1624291 |
RGD |
| G |
Pax8 |
paired box 8 |
|
|
ISO |
3 |
2,671,478 |
2,726,801 |
RGD:1624291 |
RGD |
| G |
Pax8 |
paired box 8 |
|
|
ISS |
3 |
2,671,478 |
2,726,801 |
RGD:1600115 |
UniProtKB |
positive regulation of triglyceride biosynthetic process
|
| G |
Acsl5 |
acyl-CoA synthetase long-chain family member 5 |
|
|
IDA |
1 |
261,554,383 |
261,599,373 |
RGD:2312807 |
RGD |
| G |
Acsl6 |
acyl-CoA synthetase long-chain family member 6 |
|
|
IGI |
10 |
39,729,805 |
39,778,106 |
RGD:2312800 |
RGD |
| G |
Cnep1r1 |
CTD nuclear envelope phosphatase 1 regulatory subunit 1 |
|
|
IEA |
19 |
20,245,264 |
20,259,563 |
RGD:1600115 |
ENSEMBL |
| G |
Cnep1r1 |
CTD nuclear envelope phosphatase 1 regulatory subunit 1 |
|
|
ISO |
19 |
20,245,264 |
20,259,563 |
RGD:1624291 |
RGD |
| G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
|
|
ISO |
10 |
56,826,157 |
56,835,292 |
RGD:1624291 |
RGD |
| G |
Ctdnep1 |
CTD nuclear envelope phosphatase 1 |
|
|
ISS |
10 |
56,826,157 |
56,835,292 |
RGD:1600115 |
UniProtKB |
| G |
Gpam |
glycerol-3-phosphate acyltransferase, mitochondrial |
|
|
IDA |
1 |
261,370,264 |
261,431,434 |
RGD:2313665 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISO |
17 |
47,145,567 |
47,188,345 |
RGD:1624291 |
RGD |
| G |
Gpld1 |
glycosylphosphatidylinositol specific phospholipase D1 |
|
|
ISS |
17 |
47,145,567 |
47,188,345 |
RGD:1600115 |
UniProtKB |
| G |
Ldlr |
low density lipoprotein receptor |
|
|
ISO |
8 |
20,824,040 |
20,846,920 |
RGD:1624291 |
RGD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
|
ISO |
1 |
95,027,197 |
95,032,516 |
RGD:1624291 |
RGD |
| G |
Nr1h2 |
nuclear receptor subfamily 1, group H, member 2 |
|
|
IEA |
1 |
95,027,197 |
95,032,516 |
RGD:1600115 |
ENSEMBL |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
|
ISO |
3 |
75,542,211 |
75,550,793 |
RGD:1624291 |
RGD |
| G |
Nr1h3 |
nuclear receptor subfamily 1, group H, member 3 |
|
|
IEA |
3 |
75,542,211 |
75,550,793 |
RGD:1600115 |
ENSEMBL |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
|
ISO |
12 |
32,390,183 |
32,457,661 |
RGD:1624291 |
RGD |
| G |
Scarb1 |
scavenger receptor class B, member 1 |
|
|
IEA |
12 |
32,390,183 |
32,457,661 |
RGD:1600115 |
ENSEMBL |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISS |
10 |
46,461,684 |
46,483,646 |
RGD:1600115 |
UniProtKB |
positive regulation of triglyceride catabolic process
|
| G |
Aadac |
arylacetamide deacetylase |
|
|
ISO |
2 |
149,348,935 |
149,360,181 |
RGD:1624291 |
RGD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
|
ISO |
8 |
122,148,937 |
122,173,147 |
RGD:1624291 |
RGD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
|
ISO |
8 |
122,148,937 |
122,173,147 |
RGD:1624291 |
RGD |
| G |
Abhd5 |
abhydrolase domain containing 5 |
|
|
ISS |
8 |
122,148,937 |
122,173,147 |
RGD:1600115 |
UniProtKB |
| G |
Apoa4 |
apolipoprotein A-IV |
|
|
ISO |
8 |
49,233,142 |
49,233,431 |
RGD:1624291 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
ISO |
8 |
49,253,538 |
49,255,777 |
RGD:1624291 |
RGD |
| G |
Apoa5 |
apolipoprotein A-V |
|
|
IEA |
8 |
49,253,538 |
49,255,777 |
RGD:1600115 |
ENSEMBL |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
ISO |
1 |
78,979,034 |
78,984,002 |
RGD:1624291 |
RGD |
| G |
Apoc2 |
apolipoprotein C-II |
|
|
IEA |
1 |
78,979,034 |
78,984,002 |
RGD:1600115 |
ENSEMBL |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
|
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:1624291 |
RGD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
|
ISO |
1 |
201,641,939 |
201,647,021 |
RGD:1624291 |
RGD |
| G |
Pnpla2 |
patatin-like phospholipase domain containing 2 |
|
|
ISS |
1 |
201,641,939 |
201,647,021 |
RGD:1600115 |
UniProtKB |
positive regulation of vitamin D biosynthetic process
|
| G |
Ifng |
interferon gamma |
|
|
ISO |
7 |
57,621,756 |
57,625,792 |
RGD:1624291 |
RGD |
| G |
Ifng |
interferon gamma |
|
|
IEA |
7 |
57,621,756 |
57,625,792 |
RGD:1600115 |
ENSEMBL |
| G |
Tnf |
tumor necrosis factor |
|
|
ISO |
20 |
3,661,000 |
3,663,618 |
RGD:1624291 |
RGD |
| G |
Tnf |
tumor necrosis factor |
|
|
IEA |
20 |
3,661,000 |
3,663,618 |
RGD:1600115 |
ENSEMBL |
regulation of acetyl-CoA biosynthetic process from pyruvate
|
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
|
ISS |
10 |
83,710,448 |
83,724,973 |
RGD:1600115 |
UniProtKB |
| G |
Pdk3 |
pyruvate dehydrogenase kinase, isozyme 3 |
|
|
IEA |
X |
81,104,667 |
81,171,536 |
RGD:1600115 |
ENSEMBL |
| G |
Pdk3 |
pyruvate dehydrogenase kinase, isozyme 3 |
|
|
ISO |
X |
81,104,667 |
81,171,536 |
RGD:1624291 |
RGD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:1624291 |
RGD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
IEA |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
ENSEMBL |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
regulation of acyl-CoA biosynthetic process
|
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:1624291 |
RGD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
ISO |
4 |
89,613,731 |
89,722,807 |
RGD:1624291 |
RGD |
| G |
Snca |
synuclein, alpha (non A4 component of amyloid precursor) |
|
|
IEA |
4 |
89,613,731 |
89,722,807 |
RGD:1600115 |
ENSEMBL |
regulation of adenylate cyclase activity
|
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
|
ISO |
7 |
10,203,112 |
10,271,719 |
RGD:1624291 |
RGD |
| G |
Gng7 |
guanine nucleotide binding protein (G protein), gamma 7 |
|
|
IEA |
7 |
10,203,112 |
10,271,719 |
RGD:1600115 |
ENSEMBL |
| G |
Htr4 |
5-hydroxytryptamine (serotonin) receptor 4, G protein-coupled |
|
|
IEA |
18 |
58,417,163 |
58,468,888 |
RGD:1600115 |
InterPro |
| G |
Npffr1 |
neuropeptide FF receptor 1 |
|
|
IEA |
20 |
28,983,735 |
28,995,194 |
RGD:1600115 |
InterPro |
| G |
Npffr2 |
neuropeptide FF receptor 2 |
|
|
IEA |
14 |
20,041,856 |
20,050,499 |
RGD:1600115 |
InterPro |
regulation of aldosterone metabolic process
|
| G |
Kcnma1 |
potassium large conductance calcium-activated channel, subfamily M, alpha member 1 |
|
|
ISO |
15 |
575,136 |
950,275 |
RGD:1624291 |
RGD |
regulation of bile acid biosynthetic process
|
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
|
ISO |
5 |
19,707,159 |
19,716,856 |
RGD:1624291 |
RGD |
| G |
Cyp7a1 |
cytochrome P450, family 7, subfamily a, polypeptide 1 |
|
|
IDA |
5 |
19,707,159 |
19,716,856 |
RGD:70534 |
UniProtKB |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISO |
17 |
15,512,144 |
15,527,348 |
RGD:1624291 |
RGD |
| G |
Fgfr4 |
fibroblast growth factor receptor 4 |
|
|
ISS |
17 |
15,512,144 |
15,527,348 |
RGD:1600115 |
UniProtKB |
| G |
Sirt1 |
sirtuin 1 |
|
|
IEA |
20 |
25,675,302 |
25,686,494 |
RGD:1600115 |
ENSEMBL |
| G |
Sirt1 |
sirtuin 1 |
|
|
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:1624291 |
RGD |
regulation of cAMP biosynthetic process
|
| G |
Arrb1 |
arrestin, beta 1 |
|
|
TAS |
1 |
156,871,564 |
156,937,540 |
RGD:631798 |
RGD |
| G |
Arrb2 |
arrestin, beta 2 |
|
|
TAS |
10 |
57,244,071 |
57,284,166 |
RGD:631798 |
RGD |
| G |
Gabbr1 |
gamma-aminobutyric acid (GABA) B receptor 1 |
|
|
IDA |
20 |
1,553,297 |
1,582,426 |
RGD:2315483 |
RGD |
regulation of cAMP catabolic process
|
| G |
Arrb1 |
arrestin, beta 1 |
|
|
TAS |
1 |
156,871,564 |
156,937,540 |
RGD:631798 |
RGD |
| G |
Arrb2 |
arrestin, beta 2 |
|
|
TAS |
10 |
57,244,071 |
57,284,166 |
RGD:631798 |
RGD |
regulation of cAMP metabolic process
|
| G |
Cep290 |
centrosomal protein 290 |
|
|
ISO |
7 |
38,138,545 |
38,228,716 |
RGD:1624291 |
RGD |
| G |
Drd2 |
dopamine receptor D2 |
|
|
ISO |
8 |
52,641,160 |
52,707,749 |
RGD:1624291 |
RGD |
| G |
Drd3 |
dopamine receptor D3 |
|
|
ISO |
11 |
58,446,901 |
58,520,589 |
RGD:1624291 |
RGD |
| G |
Drd3 |
dopamine receptor D3 |
|
|
IDA |
11 |
58,446,901 |
58,520,589 |
|
BHF-UCL |
| G |
Hrh1 |
histamine receptor H 1 |
|
|
IEA |
4 |
150,431,239 |
150,432,699 |
RGD:1600115 |
InterPro |
| G |
Hrh2 |
histamine receptor H 2 |
|
|
IEA |
17 |
16,497,967 |
16,499,043 |
RGD:1600115 |
InterPro |
| G |
Nphp3 |
nephronophthisis 3 (adolescent) |
|
|
ISO |
8 |
109,065,400 |
109,105,882 |
RGD:1624291 |
RGD |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
|
IEA |
14 |
6,349,519 |
6,392,988 |
RGD:1600115 |
ENSEMBL |
| G |
Pkd2 |
polycystic kidney disease 2 (autosomal dominant) |
|
|
ISO |
14 |
6,349,519 |
6,392,988 |
RGD:1624291 |
RGD |
| G |
Timp2 |
TIMP metallopeptidase inhibitor 2 |
|
|
ISO |
10 |
108,310,473 |
108,358,821 |
RGD:1624291 |
RGD |
regulation of carbohydrate metabolic process
|
| G |
Gcg |
glucagon |
|
|
TAS |
3 |
44,433,180 |
44,438,004 |
RGD:728574 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
IDA |
5 |
165,531,402 |
165,640,899 |
RGD:1625611 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
IMP |
5 |
165,531,402 |
165,640,899 |
RGD:1625611 |
RGD |
| G |
Nr1h4 |
nuclear receptor subfamily 1, group H, member 4 |
|
|
IMP |
7 |
26,189,759 |
26,307,061 |
RGD:1625077 |
RGD |
regulation of cellular amino acid metabolic process
|
| G |
Ins2 |
insulin 2 |
|
|
ISO |
1 |
202,935,548 |
202,936,379 |
RGD:1624291 |
RGD |
regulation of ceramide biosynthetic process
|
| G |
Samd8 |
sterile alpha motif domain containing 8 |
|
|
ISO |
15 |
2,569,527 |
2,612,834 |
RGD:1624291 |
RGD |
| G |
Samd8 |
sterile alpha motif domain containing 8 |
|
|
IEA |
15 |
2,569,527 |
2,612,834 |
RGD:1600115 |
ENSEMBL |
regulation of cGMP biosynthetic process
|
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
IEA |
15 |
45,589,222 |
45,717,866 |
RGD:1600115 |
ENSEMBL |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:1624291 |
RGD |
regulation of cGMP metabolic process
|
| G |
Aipl1 |
aryl hydrocarbon receptor-interacting protein-like 1 |
|
|
ISO |
10 |
58,879,846 |
58,913,985 |
RGD:1624291 |
RGD |
| G |
Aipl1 |
aryl hydrocarbon receptor-interacting protein-like 1 |
|
|
ISO |
10 |
58,879,846 |
58,913,985 |
RGD:1624291 |
RGD |
| G |
Aipl1 |
aryl hydrocarbon receptor-interacting protein-like 1 |
|
|
IEA |
10 |
58,879,846 |
58,913,985 |
RGD:1600115 |
ENSEMBL |
| G |
Cbs |
cystathionine beta synthase |
|
|
ISO |
20 |
10,047,478 |
10,075,520 |
RGD:1624291 |
RGD |
| G |
LOC100359572 |
luteinizing hormone beta-like |
|
|
IEA |
1 |
95,890,271 |
95,892,422 |
RGD:1600115 |
ENSEMBL |
regulation of cholesterol biosynthetic process
|
| G |
Apob |
apolipoprotein B |
|
|
ISO |
6 |
31,508,060 |
31,548,083 |
RGD:1624291 |
RGD |
| G |
Apob |
apolipoprotein B |
|
|
IEA |
6 |
31,508,060 |
31,548,083 |
RGD:1600115 |
ENSEMBL |
| G |
Cyp51 |
cytochrome P450, family 51 |
|
|
TAS |
4 |
26,752,677 |
26,771,131 |
RGD:1298863 |
RGD |
| G |
Dhcr7 |
7-dehydrocholesterol reductase |
|
|
IDA |
1 |
204,245,562 |
204,258,913 |
RGD:632010 |
RGD |
| G |
Mvk |
mevalonate kinase |
|
|
NAS |
|
|
|
RGD:728935 |
RGD |
| G |
Pex2 |
peroxisomal biogenesis factor 2 |
|
|
ISO |
2 |
98,361,891 |
98,378,715 |
RGD:1624291 |
RGD |
| G |
Pex2 |
peroxisomal biogenesis factor 2 |
|
|
IEA |
2 |
98,361,891 |
98,378,715 |
RGD:1600115 |
ENSEMBL |
| G |
Scap |
SREBF chaperone |
|
|
ISO |
8 |
114,706,479 |
114,761,342 |
RGD:1624291 |
RGD |
| G |
Scap |
SREBF chaperone |
|
|
IEA |
8 |
114,706,479 |
114,761,342 |
RGD:1600115 |
ENSEMBL |
regulation of cholesterol esterification
|
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
|
ISO |
20 |
9,390,485 |
9,459,574 |
RGD:1624291 |
RGD |
| G |
Abcg1 |
ATP-binding cassette, subfamily G (WHITE), member 1 |
|
|
IEA |
20 |
9,390,485 |
9,459,574 |
RGD:1600115 |
ENSEMBL |
| G |
Lamtor1 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
|
|
ISO |
1 |
159,367,471 |
159,373,042 |
RGD:1624291 |
RGD |
| G |
Lamtor1 |
late endosomal/lysosomal adaptor, MAPK and MTOR activator 1 |
|
|
ISS |
1 |
159,367,471 |
159,373,042 |
RGD:1600115 |
UniProtKB |
regulation of cholesterol metabolic process
|
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
ISO |
9 |
65,613,130 |
65,651,775 |
RGD:1624291 |
RGD |
| G |
Acadl |
acyl-CoA dehydrogenase, long chain |
|
|
IEA |
9 |
65,613,130 |
65,651,775 |
RGD:1600115 |
ENSEMBL |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
ISO |
10 |
56,856,233 |
56,861,380 |
RGD:1624291 |
RGD |
| G |
Acadvl |
acyl-CoA dehydrogenase, very long chain |
|
|
IEA |
10 |
56,856,233 |
56,861,380 |
RGD:1600115 |
ENSEMBL |
| G |
Arv1 |
ARV1 homolog (S. cerevisiae) |
|
|
ISO |
19 |
54,904,721 |
54,916,541 |
RGD:1624291 |
RGD |
| G |
Arv1 |
ARV1 homolog (S. cerevisiae) |
|
|
IEA |
19 |
54,904,721 |
54,916,541 |
RGD:1600115 |
ENSEMBL |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
|
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:1624291 |
RGD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
|
ISO |
15 |
45,497,660 |
45,556,101 |
RGD:1624291 |
RGD |
| G |
Ephx2 |
epoxide hydrolase 2, cytoplasmic |
|
|
IEA |
15 |
45,497,660 |
45,556,101 |
RGD:1600115 |
ENSEMBL |
| G |
Lmf1 |
lipase maturation factor 1 |
|
|
ISO |
10 |
14,831,884 |
14,918,491 |
RGD:1624291 |
RGD |
| G |
Por |
P450 (cytochrome) oxidoreductase |
|
|
IMP |
12 |
22,078,629 |
22,097,301 |
RGD:2316785 |
RGD |
| G |
Thrb |
thyroid hormone receptor beta |
|
|
IMP |
15 |
9,282,845 |
9,345,506 |
RGD:2315101 |
RGD |
regulation of cyclic nucleotide biosynthetic process
|
| G |
Guca2b |
guanylate cyclase activator 2B |
|
|
IDA |
5 |
140,237,184 |
140,239,234 |
RGD:731150 |
RGD |
regulation of fatty acid beta-oxidation
|
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
|
TAS |
1 |
205,852,800 |
205,912,972 |
RGD:1600733 |
RGD |
| G |
Lonp2 |
lon peptidase 2, peroxisomal |
|
|
IEA |
19 |
21,785,263 |
21,838,495 |
RGD:1600115 |
ENSEMBL |
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
|
IDA |
19 |
49,637,193 |
49,653,016 |
RGD:1600797 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
IDA |
5 |
165,531,402 |
165,640,899 |
RGD:1625611 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
IMP |
5 |
165,531,402 |
165,640,899 |
RGD:1625611 |
RGD |
| G |
Tysnd1 |
trypsin domain containing 1 |
|
|
ISS |
20 |
29,062,966 |
29,068,684 |
RGD:1600115 |
UniProtKB |
| G |
Tysnd1 |
trypsin domain containing 1 |
|
|
ISO |
20 |
29,062,966 |
29,068,684 |
RGD:1624291 |
RGD |
regulation of fatty acid biosynthetic process
|
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:1624291 |
RGD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
IEA |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
ENSEMBL |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
| G |
Scap |
SREBF chaperone |
|
|
ISO |
8 |
114,706,479 |
114,761,342 |
RGD:1624291 |
RGD |
| G |
Scap |
SREBF chaperone |
|
|
IEA |
8 |
114,706,479 |
114,761,342 |
RGD:1600115 |
ENSEMBL |
regulation of fatty acid metabolic process
|
| G |
Ankrd26 |
ankyrin repeat domain 26 |
|
|
ISO |
4 |
154,801,803 |
154,871,524 |
RGD:1624291 |
RGD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
|
ISO |
4 |
42,956,102 |
42,989,057 |
RGD:1624291 |
RGD |
| G |
Cav1 |
caveolin 1, caveolae protein |
|
|
IEA |
4 |
42,956,102 |
42,989,057 |
RGD:1600115 |
ENSEMBL |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
|
ISO |
4 |
104,016,940 |
104,078,261 |
RGD:1624291 |
RGD |
| G |
Eif2ak3 |
eukaryotic translation initiation factor 2 alpha kinase 3 |
|
|
IEA |
4 |
104,016,940 |
104,078,261 |
RGD:1600115 |
ENSEMBL |
| G |
Fam132b |
family with sequence similarity 132, member B |
|
|
IEA |
9 |
90,593,588 |
90,599,489 |
RGD:1600115 |
ENSEMBL |
| G |
Fam132b |
family with sequence similarity 132, member B |
|
|
ISO |
9 |
90,593,588 |
90,599,489 |
RGD:1624291 |
RGD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
TAS |
7 |
123,729,774 |
123,807,090 |
RGD:729665 |
RGD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:1624291 |
RGD |
| G |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
|
ISO |
4 |
5,620,992 |
5,667,438 |
RGD:1624291 |
RGD |
| G |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
|
IEA |
4 |
5,620,992 |
5,667,438 |
RGD:1600115 |
ENSEMBL |
| G |
Scap |
SREBF chaperone |
|
|
ISO |
8 |
114,706,479 |
114,761,342 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
ISO |
10 |
46,461,684 |
46,483,646 |
RGD:1624291 |
RGD |
| G |
Srebf1 |
sterol regulatory element binding transcription factor 1 |
|
|
IEA |
10 |
46,461,684 |
46,483,646 |
RGD:1600115 |
ENSEMBL |
regulation of fatty acid oxidation
|
| G |
Cpt1a |
carnitine palmitoyltransferase 1a, liver |
|
|
IMP |
1 |
205,852,800 |
205,912,972 |
RGD:1298597 |
RGD |
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
|
IMP |
19 |
49,637,193 |
49,653,016 |
RGD:1600796 |
RGD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
regulation of glucocorticoid biosynthetic process
|
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:1624291 |
RGD |
regulation of glucocorticoid metabolic process
|
| G |
Gal |
galanin/GMAP prepropeptide |
|
|
IMP |
1 |
205,936,352 |
205,941,215 |
RGD:1624340 |
RGD |
| G |
Stub1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
|
IEA |
10 |
15,096,150 |
15,098,431 |
RGD:1600115 |
ENSEMBL |
| G |
Stub1 |
STIP1 homology and U-box containing protein 1, E3 ubiquitin protein ligase |
|
|
ISO |
10 |
15,096,150 |
15,098,431 |
RGD:1624291 |
RGD |
regulation of gluconeogenesis
|
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
|
ISO |
2 |
251,866,645 |
251,890,729 |
RGD:1624291 |
RGD |
| G |
Acadm |
acyl-CoA dehydrogenase, C-4 to C-12 straight chain |
|
|
IEA |
2 |
251,866,645 |
251,890,729 |
RGD:1600115 |
ENSEMBL |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
|
ISO |
17 |
7,795,717 |
7,818,041 |
RGD:1624291 |
RGD |
| G |
Fbp1 |
fructose-1,6-bisphosphatase 1 |
|
|
ISS |
17 |
7,795,717 |
7,818,041 |
RGD:1600115 |
UniProtKB |
| G |
Gnmt |
glycine N-methyltransferase |
|
|
ISO |
9 |
10,127,092 |
10,130,444 |
RGD:1624291 |
RGD |
| G |
Lep |
leptin |
|
|
ISO |
4 |
55,943,837 |
55,945,938 |
RGD:1624291 |
RGD |
| G |
Lep |
leptin |
|
|
IEA |
4 |
55,943,837 |
55,945,938 |
RGD:1600115 |
ENSEMBL |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
ISO |
18 |
32,371,496 |
32,459,145 |
RGD:1624291 |
RGD |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
|
ISS |
10 |
83,710,448 |
83,724,973 |
RGD:1600115 |
UniProtKB |
| G |
Slc35b4 |
solute carrier family 35, member B4 |
|
|
ISO |
4 |
61,480,810 |
61,502,818 |
RGD:1624291 |
RGD |
regulation of gluconeogenesis by regulation of transcription from RNA polymerase II promoter
|
| G |
Foxo1 |
forkhead box O1 |
|
|
ISO |
2 |
141,127,345 |
141,203,446 |
RGD:1624291 |
RGD |
regulation of glucose metabolic process
|
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISO |
11 |
79,908,291 |
79,911,065 |
RGD:1624291 |
RGD |
| G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
|
|
ISS |
11 |
79,908,291 |
79,911,065 |
RGD:1600115 |
UniProtKB |
| G |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
|
|
ISO |
10 |
108,431,984 |
108,452,099 |
RGD:1624291 |
RGD |
| G |
C1qtnf1 |
C1q and tumor necrosis factor related protein 1 |
|
|
IEA |
10 |
108,431,984 |
108,452,099 |
RGD:1600115 |
ENSEMBL |
| G |
Fam132a |
family with sequence similarity 132, member A |
|
|
ISO |
5 |
172,801,076 |
172,805,451 |
RGD:1624291 |
RGD |
| G |
Igfbp3 |
insulin-like growth factor binding protein 3 |
|
|
ISO |
14 |
87,959,153 |
87,967,085 |
RGD:1624291 |
RGD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
|
ISO |
10 |
87,822,429 |
87,834,315 |
RGD:1624291 |
RGD |
| G |
Igfbp4 |
insulin-like growth factor binding protein 4 |
|
|
IEA |
10 |
87,822,429 |
87,834,315 |
RGD:1600115 |
ENSEMBL |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
|
ISO |
9 |
72,003,637 |
72,016,263 |
RGD:1624291 |
RGD |
| G |
Igfbp5 |
insulin-like growth factor binding protein 5 |
|
|
IEA |
9 |
72,003,637 |
72,016,263 |
RGD:1600115 |
ENSEMBL |
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
|
ISO |
19 |
49,637,193 |
49,653,016 |
RGD:1624291 |
RGD |
| G |
Mlycd |
malonyl-CoA decarboxylase |
|
|
IEA |
19 |
49,637,193 |
49,653,016 |
RGD:1600115 |
ENSEMBL |
| G |
Nr3c1 |
nuclear receptor subfamily 3, group C, member 1 |
|
|
IMP |
18 |
32,371,496 |
32,459,145 |
RGD:4892117 |
RGD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
|
ISO |
3 |
54,292,076 |
54,319,242 |
RGD:1624291 |
RGD |
| G |
Pdk1 |
pyruvate dehydrogenase kinase, isozyme 1 |
|
|
ISS |
3 |
54,292,076 |
54,319,242 |
RGD:1600115 |
UniProtKB |
| G |
Pdk2 |
pyruvate dehydrogenase kinase, isozyme 2 |
|
|
ISS |
10 |
83,710,448 |
83,724,973 |
RGD:1600115 |
UniProtKB |
| G |
Pdk3 |
pyruvate dehydrogenase kinase, isozyme 3 |
|
|
IEA |
X |
81,104,667 |
81,171,536 |
RGD:1600115 |
ENSEMBL |
| G |
Pdk3 |
pyruvate dehydrogenase kinase, isozyme 3 |
|
|
ISO |
X |
81,104,667 |
81,171,536 |
RGD:1624291 |
RGD |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
IEA |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
ENSEMBL |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISS |
4 |
30,235,296 |
30,245,298 |
RGD:1600115 |
UniProtKB |
| G |
Pdk4 |
pyruvate dehydrogenase kinase, isozyme 4 |
|
|
ISO |
4 |
30,235,296 |
30,245,298 |
RGD:1624291 |
RGD |
| G |
Sirt1 |
sirtuin 1 |
|
|
IEA |
20 |
25,675,302 |
25,686,494 |
RGD:1600115 |
ENSEMBL |
| G |
Sirt1 |
sirtuin 1 |
|
|
ISO |
20 |
25,675,302 |
25,686,494 |
RGD:1624291 |
RGD |
regulation of glutamate metabolic process
|
| G |
Apc |
adenomatous polyposis coli |
|
|
IDA |
18 |
26,732,147 |
26,790,383 |
RGD:6484536 |
RGD |
regulation of glycogen biosynthetic process
|
| G |
Akt1 |
v-akt murine thymoma viral oncogene homolog 1 |
|
|
ISO |
6 |
137,640,482 |
137,657,552 |
RGD:1624291 |
RGD |
| G |
Inpp5k |
inositol polyphosphate-5-phosphatase K |
|
|
ISO |
10 |
62,953,425 |
62,971,016 |
RGD:1624291 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
IDA |
5 |
165,531,402 |
165,640,899 |
RGD:1625611 |
RGD |
| G |
Mtor |
mechanistic target of rapamycin (serine/threonine kinase) |
|
|
IMP |
5 |
165,531,402 |
165,640,899 |
RGD:1625611 |
RGD |
| G |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
|
IDA |
1 |
206,774,719 |
206,778,336 |
RGD:2304267 |
RGD |
| G |
Ppp1cb |
protein phosphatase 1, catalytic subunit, beta isozyme |
|
|
IDA |
6 |
24,067,544 |
24,099,280 |
RGD:2304267 |
RGD |
| G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
|
|
IDA |
16 |
60,552,431 |
60,564,789 |
RGD:2304267 |
RGD |
| G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
|
|
IDA |
16 |
60,552,431 |
60,564,789 |
RGD:2306167 |
RGD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
|
IDA |
1 |
240,991,884 |
240,996,887 |
RGD:2306167 |
RGD |
| G |
Ppp1r3d |
protein phosphatase 1, regulatory subunit 3D |
|
|
IDA |
3 |
167,505,678 |
167,508,749 |
RGD:2306167 |
RGD |
| G |
Ppp1r3e |
protein phosphatase 1, regulatory subunit 3E |
|
|
IDA |
15 |
32,974,172 |
32,975,332 |
RGD:2306166 |
RGD |
regulation of glycogen catabolic process
|
| G |
Ppp1ca |
protein phosphatase 1, catalytic subunit, alpha isozyme |
|
|
IDA |
1 |
206,774,719 |
206,778,336 |
RGD:2304267 |
RGD |
| G |
Ppp1cb |
protein phosphatase 1, catalytic subunit, beta isozyme |
|
|
IDA |
6 |
24,067,544 |
24,099,280 |
RGD:2304267 |
RGD |
| G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
|
|
IDA |
16 |
60,552,431 |
60,564,789 |
RGD:2304267 |
RGD |
| G |
Ppp1r3b |
protein phosphatase 1, regulatory subunit 3B |
|
|
IDA |
16 |
60,552,431 |
60,564,789 |
RGD:2306167 |
RGD |
| G |
Ppp1r3c |
protein phosphatase 1, regulatory subunit 3C |
|
|
IDA |
1 |
240,991,884 |
240,996,887 |
RGD:2306167 |
RGD |
| G |
Ppp1r3d |
protein phosphatase 1, regulatory subunit 3D |
|
|
IDA |
3 |
167,505,678 |
167,508,749 |
RGD:2306167 |
RGD |
| G |
Ppp1r3e |
protein phosphatase 1, regulatory subunit 3E |
|
|
IDA |
15 |
32,974,172 |
32,975,332 |
RGD:2306166 |
RGD |
regulation of glycolysis
|
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
ISO |
6 |
96,419,024 |
96,463,891 |
RGD:1624291 |
RGD |
| G |
Hif1a |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) |
|
|
IEA |
6 |
96,419,024 |
96,463,891 |
RGD:1600115 |
ENSEMBL |
| G |
Il3 |
interleukin 3 |
|
|
ISO |
10 |
39,684,691 |
39,687,041 |
RGD:1624291 |
RGD |
| G |
Il3 |
interleukin 3 |
|
|
IEA |
10 |
39,684,691 |
39,687,041 |
RGD:1600115 |
ENSEMBL |
| G |
Mlxipl |
MLX interacting protein-like |
|
|
IDA |
|
|
|
RGD:634534 |
RGD |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
|
IEA |
X |
89,721,369 |
89,766,218 |
RGD:1600115 |
ENSEMBL |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
|
ISS |
X |
89,721,369 |
89,766,218 |
RGD:1600115 |
UniProtKB |
| G |
Ogt |
O-linked N-acetylglucosamine (GlcNAc) transferase |
|
|
ISO |
X |
89,721,369 |
89,766,218 |
RGD:1624291 |
RGD |
| G |
Pfkfb3 |
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 |
|
|
TAS |
17 |
78,241,182 |
78,268,272 |
RGD:729510 |
RGD |
| G |
Pgam1 |
phosphoglycerate mutase 1 (brain) |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
|
ISO |
4 |
5,620,992 |
5,667,438 |
RGD:1624291 |
RGD |
| G |
Prkag2 |
protein kinase, AMP-activated, gamma 2 non-catalytic subunit |
|
|
IEA |
4 |
5,620,992 |
5,667,438 |
RGD:1600115 |
ENSEMBL |
regulation of glycolysis by negative regulation of transcription from RNA polymerase II promoter
|
| G |
Ncor1 |
nuclear receptor co-repressor 1 |
|
|
ISO |
10 |
48,481,110 |
48,628,538 |
RGD:1624291 |
RGD |
regulation of glycolysis by positive regulation of transcription from RNA polymerase II promoter
|
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
ISO |
7 |
123,729,774 |
123,807,090 |
RGD:1624291 |
RGD |
| G |
Ppara |
peroxisome proliferator activated receptor alpha |
|
|
IEA |
7 |
123,729,774 |
123,807,090 |
RGD:1600115 |
ENSEMBL |
regulation of guanylate cyclase activity
|
| G |
Guca1a |
guanylate cyclase activator 1a (retina) |
|
|
ISO |
9 |
9,046,617 |
9,056,984 |
RGD:1624291 |
RGD |
| G |
Guca1b |
guanylate cyclase activator 1B |
|
|
ISO |
9 |
9,058,038 |
9,065,831 |
RGD:1624291 |
RGD |
| G |
Guca2a |
guanylate cyclase activator 2a (guanylin) |
|
|
NAS |
5 |
140,227,304 |
140,229,146 |
RGD:728502 |
GOC |
regulation of inositol trisphosphate biosynthetic process
|
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISS |
15 |
45,589,222 |
45,717,866 |
RGD:1600115 |
UniProtKB |
| G |
Ptk2b |
protein tyrosine kinase 2 beta |
|
|
ISO |
15 |
45,589,222 |
45,717,866 |
RGD:1624291 |
RGD |
regulation of lipid biosynthetic process
|
| G |
Mid1ip1 |
MID1 interacting protein 1 |
|
|
IMP |
X |
24,205,679 |
24,207,860 |
|
UniProtKB |
| G |
Thrsp |
thyroid hormone responsive |
|
|
ISO |
1 |
154,647,339 |
154,651,663 |
RGD:1624291 |
RGD |
| G |
Thrsp |
thyroid hormone responsive |
|
|
ISS |
1 |
154,647,339 |
154,651,663 |
RGD:1600115 |
UniProtKB |
| G |
Thrsp |
thyroid hormone responsive |
|
|
IMP |
1 |
154,647,339 |
154,651,663 |
|
UniProtKB |
regulation of lipid catabolic process
|
| G |
Thra |
thyroid hormone receptor alpha |
|
|
ISO |
10 |
87,514,443 |
87,542,306 |
RGD:1624291 |
RGD |
| G |
Thra |
thyroid hormone receptor alpha |
|
|
IEA |
10 |
87,514,443 |
87,542,306 |
RGD:1600115 |
ENSEMBL |
regulation of lipid kinase activity
|
| G |
Rb1 |
retinoblastoma 1 |
|
|
ISO |
15 |
53,828,881 |
53,962,099 |
RGD:1624291 |
RGD |
| G |
Rb1 |
retinoblastoma 1 |
|
|
ISS |
15 |
53,828,881 |
53,962,099 |
RGD:1600115 |
UniProtKB |
| G |
Rbl1 |
retinoblastoma-like 1 (p107) |
|
|
ISO |
3 |
147,734,622 |
147,796,630 |
RGD:1624291 |
RGD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
|
ISO |
19 |
17,045,131 |
17,092,597 |
RGD:1624291 |
RGD |
| G |
Rbl2 |
retinoblastoma-like 2 |
|
|
IEA |
19 |
17,045,131 |
17,092,597 |
RGD:1600115 |
ENSEMBL |
regulation of lipid metabolic process
|
| G |
Acer1 |
alkaline ceramidase 1 |
|
|
ISO |
|
|
|
RGD:1624291 |
RGD |
| G |
Angptl4 |
angiopoietin-like 4 |
|
|
TAS |
7 |
16,261,623 |
16,267,852 |
RGD:1578348 |
RGD |
| G |
Ankrd26 |
ankyrin repeat domain 26 |
|
|
ISO |
4 |
154,801,803 |
154,871,524 |
RGD:1624291 |
RGD |
| G |
Bbs4 |
Bardet-Biedl syndrome 4 |
|
|
ISO |
8 |
63,153,456 |
63,189,904 |
RGD:1624291 |
RGD |
| G |
Bbs4 |
Bardet-Biedl syndrome 4 |
![GBrowse link GBrowse link]() | |